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ABSTRACT	   	  
      Using a microchannel assay, we demonstrate that cells adopt distinct signaling 
strategies to modulate cell migration in different physical microenvironments. We 
studied α4β1 integrin-mediated signaling, which regulates cell migration pertinent to 
embryonic development, leukocyte trafficking and melanoma invasion. We show that 
α4β1 integrin promotes cell migration through both unconfined and confined spaces. 
However, unlike unconfined (2D) migration, which depends on enhanced Rac1 
activity achieved by preventing α4/paxillin binding, confined migration requires 
myosin II-driven contractility, which is increased when Rac1 is inhibited by 
α4/paxillin binding. This Rac1-myosin II crosstalk mechanism also controls 
migration of fibroblast-like cells lacking α4β1 integrin, in which Rac1 and myosin II 
modulate unconfined and confined migration, respectively. We further demonstrate 
the distinct roles of myosin II isoforms, MIIA and MIIB, which are primarily required 
for confined and unconfined migration, respectively.  
      Protein kinase A (PKA) works upstream to regulate phosphorylation of verious 
proteins and enzymes, including α4β1 integrin. It has been reported that PKA tightly 
regulates wide array of (patho)physiological functions. We have further employed 
FRET-based-PKA reporter (AKAR4-Kras) to investigate how cells modulate PKA 
activity spatiotemporally. We have found that the interplay of PKA, Rac1/myosin II, 
and cytoskeleton-related molecules determines efficient migration in response to 
various degrees of physical constraint. This work provides a paradigm for the 
plasticity of cells migrating through different physical microenvironments. 
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      Cell migration in different tissues occurs in variety of cell types. Migration is a 
constitutive feature for fibroblast, leukocytes, and different other kind of cells 
throughout lifetime. In general, cell migration plays critical role of maintaining 
various physiological function such as wound healing, leukocyte trafficking, 
gastrulation, and organ development. The mechanism of cell migration was first 
established on 2D migration. Cells are activated to perform multistep cycle of 
protrusion, adhesion formation, and stabilization at the leading edge followed by cell 
body translocation and release of adhesion and detachment of cell rear to complete 
movement. However, although 2D migration plays important role for heart or blood 
vessel development, migrating cells have high chance encountering various type of 
barrier and physical constraint in physiological development. Therefore simulating or 
modeling 3D migration has been developed to attempt to understand how cells 
migrate in vivo. The limitation of 3D migration is various factors such as control of 
local density, and growth factor stimulus and MMP-mediated ECM degradation could 
all physically or biochemically affect cell migration. In order to study basic 
mechanism of migration in response to physical constraint, we employed PDMS-
based microchannel assay to simulate this process. Using CHO-α4WT as model 
system, we first study the effect of outside in signaling on confined migration. 
Moreover, we compared the mechanism of confined and unconfined migration in α4 
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expressing cancer cell line, melanoma, commonly used 3T3 fibroblast cell line, and T 
cells. With these comprehensive studies, we sought to reveal the mechanism of 
migration in response to physical constraint.   
1.1 Role of integrins mediates cell migration (outside-in signaling) 
 
Integrins are major and well-defined trans-membrane receptors that mediate 
dynamic interaction and extracellular matrix and the actin cytoskeleton during cell 
migration. Integrins recognize diverse specific ligands. For example, α5β1, αvβ3, and 
α4β1 integrins are specific to different regions of fibronection, α1β1 and α2β1 are 
specific to collagen, and α2β1, α3β1, and α6β1 integrins are specific to laminin. Cell 
surface receptor is also recognized by integrins, such as ICAM-1 (αLβ2) and VCAM-
1 (α4β1).  In order to migrate, integrin mediate adhesion assembly and reassembly by 
turning over, which optimize cell migration speed and persistence. The optimal 
migration speed happens when the interaction between integrin and substrate are 
intermediate where adhesion assembly and disassembly are efficient (Huttenlocher 
and Horwitz, 2011). It has been reported that α5β1 and α2β1 play important role of 
mediating this migration process and focal adhesion are mainly formed by these two 
integrin (Askari et al., 2010; Kreis et al., 2005). However, different integrins can also 
suppress the signaling from each other, given the best example that α4β1 integrin 
inhibits α5β1-indeuced stress fiber and focal adhesion (Moyano et al., 2003). Ligand-
receptor binding not only provides physical anchor to cytoskeleton but also induces 
formation of adaptor protein complex in integrin cytoplasmic region, thus triggering 
signaling cascade that further modulates migration process.  
      α4β1-mediated 2D, confined, and 3D migration involves wide array of 
physiological process, including epicardium formation, T-cell trafficking, and 
melanoma metastasis. The α tail of α4β1 integrins also interacts with various 
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cytoskeletal proteins such as paxillin. These proteins, which directly associate with 
the tails of α4β1 integrin subunits, also interact with other proteins, forming an 
exquisitely regulated multiprotein complex that links to the actin cytoskeleton(Liu et 
al., 1999). In addition to their scaffolding function, these proteins transduce signals to 
regulate cell polarity, F-actin branching and polymerization and migration through a 
process known as “outside-in signaling”, which is itself tightly regulated. Binding of 
paxillin to the α cytoplasmic domain has been reported to recruit protein complex 
ARF-GAP which then interferes with Rac1 activation at leading edge of the 
cell(Nishiya et al., 2005). Paxillin binding to α4 is prevented by phosphorylation of a 
critical serine residue (ser-988) in the α4 cytoplasmic tail. Upon dephosphorylation of 
α4 integrin, paxillin can bind to α4β1 integrin, which then results in their 
colocalization in focal complexes at the cell front and in focal contact at cell rear (Liu 
et al., 1999). Given that efficient integrin-dependent migration is achieved by Rac1-
dependent lamellipodium induction and higher side integrin dynamics localizing at 
actin stress fibers upon RhoA activation, we know that paxillin binding and its 
prevention will modulate activities of Rac1 and RhoA, whose effects then result in 
different cell migration styles (Hung et al., 2013).  Y991A is a α4 cytoplasmic point 
mutation prevents paxillin binding and, S988A is the point mutation preventing 
phosphorylation at serine residue of α4-tail. Previous research and we have together 
shown that CHO-α4Y991A cells exhibit wider lamellipodial protrusions (i.e. fan 
shape) and migrate in a more directionally persistent manner(Pinco et al., 2002). In 
contrast, CHO-α4S988A cells display confined lamellipodia protrusion and migrate 
less directionally(Goldfinger et al., 2003). 
 
1.2 Conformation change of α4β1 integrin through inside-out signaling 
      α4β1 integrin is formed through non-covalent association of two type I 
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transmembrane glycoproteins, α4- and β1 subunit. The extracellular domains are 
approximately 700 amino acids for α- and 1000 amino acids for β subunits(Xiong et 
al., 2002). The globular head region of the extracellular domain of the α4 subunit 
participates in ligand binding by switching between close and open conformations. 
This α4 globular head region consists of seven repeats of 60 amino acids as well as an 
insertion termed I-domain that fold into a seven-bladed β propeller structure at 
inactivation state(Liddington and Ginsberg, 2002). This I-domain contains a “metal 
ion-dependent adhesion site” (MIDAS) and integrin ligand binding is altered by the 
coordination of Mg2+ ion and shifts from a closed to an open conformation. This 
process is thought to increase the binding affinity and the adhesion strength of α4β1 
integrins. The β cytoplasmic tail has been reported to associate with various 
cytoskeletal and signaling proteins, such as talin, α-actinin, tensin, and focal adhesion 
kinase(Liddington and Ginsberg, 2002). Binding of talin to the β cytoplasmic tail of 
α4β1 induces integrin conformational changes that propagate all the way up to the 
ligand-binding head domain, thereby increasing α4β1 intergin affinity. 
1.3 Using microfluidic device to study cell migration and invasion 
      Conventional transwell assay has been used for past decades. It used to be 
commonly used assay to measure cell motility and has been commercialized by 
several companies. However, it has several disadvantages such as that chemotaxis 
gradient varies over time and it is incapable of monitoring cell movement in real time. 
We have developed PDMS-based microchannel assay where stable gradient can last 
more than 15 hours and different degree of confinement can be created for the need of 
experiments(Tong et al., 2012a). Most importantly, this microschannel assay enables 
us to monitor cell morphological change during migration or invasion and it opens the 
possibility of integrating with other technologies, such as real time biosensor analysis. 
	   5	  
Moreover, the array of microchannel provides a platform to quantify and identify the 
properties of cell migration. For example, microchannels can be either coated with 
specific substrate for migration study or filled in with matrigel for the purpose if 
invasion study (Chaw et al., 2007). Cell displays completely different migration 
phenotypes in both conditions. Within matrigel filled 6µm microchannel, 
chondrosarcoma exhibits mesenchymal phenotype where high MMP activity could be 
involved. In contrast, with collagen-I coated 6µm microchannel, cell migrates in a 
more amoeboid style where protrusion-retraction cycle is not found profound.    
 
1.4 Overview of thesis 
The focus of this study has been directed toward to reveal the mechanism of confined 
migration, and mechno-sensing.  My efforts have been first concentrated with 
simulating a confined or 3D environment by employing microchannel migration 
assay, followed by series of Rac1-myosin II crosstalk study to reveal how fibroblast-
like cells adjust signaling to optimize migration in response to physical constraint 
(Chapter 2 and Chapter 3). This study also demonstrates how myosin II isoforms can 
differentially regulate cell migration in confined and unconfined spaces in Chapter 4. 
Other than fibroblast-like cell lines, we also discovered both amoeboid artificial T-
cell and in vivo T-cell use Rac1-myosin II balance to regulate confined versus 
unconfined migration, which is described in Chapter 5. Using FRET-based biosensor, 
Chapter 6 presents protein kinase A, which is upstream of α4 and many other factors, 
is locally modulated in response to physical confinement. We have summarized and 
discussed the biological significance, proposed signaling pathway of confined 
migration, and possible source of mechano-sensor in Chapter 7. Several suggested 
lines for future work are presented in Chapter 8.  




α4β1 integrin regulates confined versus unconfined 
migration 
2.1 Introduction  
Using a Chinese hamster ovary (CHO) cell model, it was demonstrated that 
α4β1 integrin promotes lamellipodia protrusion and directionally persistent cell 
migration, which are regulated by molecular interactions at the cytoplasmic tail of the 
α4 integrin subunit (α4 tail) (Goldfinger et al., 2003; Lim et al., 2007; Rivera Rosado 
et al., 2011). The best studied interaction at the α4 tail involves its binding to paxillin 
(Liu et al., 1999), which forms an α4-paxillin-GIT1 complex that inhibits Rac1 
activation (Nishiya et al., 2005). α4/paxillin binding is negatively regulated by PKA-
dependent phosphorylation of Ser988 in the α4 tail (Ser988-phosphorylation) (Han et 
al., 2001). α4β1 integrin-dependent cell migration on a two-dimensional (2D) 
substratum is suppressed when Ser988-phosphorylation is disrupted by substitution of 
Ser988 with Ala (S988A mutation) but enhanced when α4/paxillin binding is 
disrupted by substitution of Tyr991 with Ala (Y991A mutation). α4/paxillin binding 
and Ser988-phosphorylation differentially modulate Rac1 activation, thus regulating 
lamellipodia protrusion and directionally persistent cell migration on a 2D surface 
(Goldfinger et al., 2003; Nishiya et al., 2005). However, it is not known how the 
molecular interactions at the α4 tail regulate cell migration through physically 
confined, as opposed to unconfined (2D), microenvironments encountered in vivo.  
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 Cells migrate in vivo within 3D ECMs. Cells also migrate through 3D 
longitudinal tracks with bordering 2D interfaces (i.e. channels). These channels are 
formed between the connective tissue and the basement membrane of muscle, nerve 
and epithelium (Friedl and Alexander, 2011). 3D longitudinal channels are also 
formed between adjacent bundled collagen fibers in fibrillar interstitial tissues (Friedl 
and Alexander, 2011). Importantly, cells have been reported to migrate through such 
3D channels in vivo (Alexander et al., 2008). The cross-sectional areas (Wolf et al., 
2009) of pores/channels encountered in vivo range from 10 to >400 µm2. 
Consequently, cells migrating in vivo experience varying degrees of physical 
confinement. Accumulating evidence suggests that physical confinement alters cell 
migration mechanisms (Balzer et al., 2012; Konstantopoulos et al., 2013; Pathak and 
Kumar, 2012). To address how α4 tail-mediated signaling regulates cell migration in 
physically confined microenvironments, we used a microchannel device (Balzer et al., 
2012; Chen et al., 2013; Tong et al., 2012a), which tracks cells migrating through 4-
walled channels of varying degrees of confinement; from unconfined (2D) migration 
when the channel width, W, is larger than the cell diameter, dcell, (wide channels) to 
confined migration when W<dcell (narrow channels). 
 
2.2 Materials & Methods 
2.2.1 cell culture  
 
CHO-α4WT, CHO-α4Y991A, or CHO-α4S988A cell lines were generated by 
stably transfecting CHO cells with pQN4G, pQN4Y991AG or pQN4S988AG 
plasmids, in which wild-type or mutant α4 integrin cDNA was inserted into a 
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PGBI25-fN1 GFP vector (Dikeman et al., 2008; Pinco et al., 2002). The cells were 
maintained in Ham’s F12 (Cellgro, 10-080-CM, company) medium.  
2.2.2 flow cytometry  
Flow	  cytometry,	  immunoprecipitation,	  and	  immunoblot	  analysis	  were	  
performed	  as	  described	  by	  Pinco	  et	  al.(Pinco	  et	  al.,	  2002)	  For	  flow	  cytometry,	  an	  
anti-­‐α4-­‐integrin	  antibody	  (clone	  P1H4	  from	  Millipore-­‐Chemicon)	  and	  a	  goat	  
anti-­‐mouse	  allophycocyanin-­‐conjugated	  secondary	  antibody	  (Santa	  Cruz	  
Biotechnology)	  were	  used. 
2.2.3 microfluidic-based microchannel assay  
 
PDMS microchannels were fabricated using standard replica molding. Masks to 
generate the microchannel design were drawn using Adobe Illustrator CS2 and 
printed onto a transparency by a 5080 dpi printer (Pageworks) or transferred to a 
chrome-on-glass photolithography mask (Advance Reproductions Corp.). To prepare 
masters, SU-8 2010 and SU-8 2025 epoxy negative photoresists (Microchem Corp.) 
were applied by spin coating (Laurell Technologies Corp.) onto silicon wafers 
(Montco Silicon Technologies Inc.) in two steps. SU-8 2010 was first spread at 600 
rpm for 20 s and then at 4000 rpm for 60 s to a final thickness of 8-10 µm. The 
photoresist was prebaked at 60 °C for 1 min, exposed to UV (350−450 nm) radiation 
through appropriate masks for 40 s, postbaked at 115 °C for 8 min, and subsequently 
developed using SU-8 developer (Microchem Corp.). This step was used for 
generating the microchannels present in the final device. The second feature of the 
microfluidic-based microchannel master consisted of the cell seeding line and the 
FBS gradient generation line, and was fabricated using the following steps: SU-8 
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2025 was first spread at 500 rpm for 10 s and then at 4000 rpm for 30 s to a final 
thickness of 50 µm. The photoresist was prebaked at 80 °C for 3 min and at 110 °C 
for 6 min, cooled, and exposed to UV (350−450 nm) radiation for 30 s through a 
mask aligned with the previously fabricated microchannels. The photoresist was then 
exposed for 8 min at 110 °C and developed as before. PDMS stamps were obtained 
by mixing Sylgard 184 prepolymer with cross-linker (Dow Corning) in a 10:1 ratio 
(by weight), degassing in a vacuum, and curing at 80 °C for 1 h. Each PDMS well 
inlet and outlet was punched out with a diameter of 6 mm. Both the PDMS device and 
microscope slide (FisherFinest) were cleaned and made hydrophilic using a plasma 
cleaner for 2 min. The PDMS device was then attached to a glass slide, followed by 
pre-coating various concentrations of VCAM-1 at 37 °C for 1 h. The microchannel 
was washed with PBS (1X) containing calcium/magnesium for 1 min before seeding 
cells. A total of 1x105 cells in a 50 µl volume were added to the cell inlet port. 
Chemotactic-driven cell migration was recorded via time-lapse microscopy (inverted 
Eclipse Ti microscope, Nikon) using software controlled stage automation (Nikon). 
To calculate migration velocity, the cell center was identified as the midpoint between 
poles of the cell body, and was tracked for changes in X, Y position at 20-min 
intervals or 5-min intervals only for CD4+ T cells over a 10 h period.  
2.3 Results & Discussion 
2.3.1 overview of using microchannel assay on CHO cells expressing α4 
 
To study the effects of α4 cytoplasmic tail interactions on cell migration, we 
used stable CHO cell lines, which ectopically express the wild-type α4 integrin 
(CHO-α4WT) or α4 integrin carrying specific cytoplasmic mutations that disrupt 
paxillin binding (CHO-α4Y991A) or Ser988-phosphorylation (CHO-α4S988A) 
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(Dikeman et al., 2008; Pinco et al., 2002). We confirmed that CHO-α4WT, CHO-
α4Y991A and CHO-α4S988A cells express equivalent levels of α4 integrin on their 
surface, as assessed by flow cytometry (Fig. 2-1). We tested the migratory potential 
of each cell type in a microchannel assay (Balzer et al., 2012; Chen et al., 2013; Tong 
et al., 2012a). In this assay, cells migrate toward a chemoattractant source through 
VCAM-1- or fibronectin-coated, 4-walled rectangular channels of fixed length (200 
µm) and height (10 µm) but variable width (3, 6, 10, 20 or 50 µm) (Fig. 1). Cells 
migrating through 50-µm wide channels are not constricted by the PDMS channel 
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Figure 2-1 α4 expressing level of CHO-α4WT, CHO-α4Y991A and CHO-
α4S988A cells. Demonstrates surface expression of α4 integrin in CHO-α4WT, 
CHO-α4Y991A and CHO-α4S988A cells. Fig. S2 details quantitative analysis of 
velocity, speed and chemotactic index of α4 integrin-expressing CHO, A375-SM and 
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Figure 2-2 Overview of the microchannel device. Schematic of the migration 
chamber bonded to coverslips (light blue), with inlet ports for serum-free media or 
cells (dark blue) or FBS (10%; green). Also shown is a close-up detailing the 
dimensions of the microchannel array, along with phase contrast and 3D 
reconstruction images of CHO-α4WT cells in microchannels of different widths. The 
black arrow (above the phase images) indicates the direction of migration.  
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2.3.2 α4 tail mutations exert distinct effects on wide versus narrow channel migration 
We then evaluated the effect of VCAM-1 concentration on the speed of cell 
migration. As shown in Fig. 2-3 A, all cell types migrating through 50-µm wide 
channels exhibited a biphasic dependence of the migration speed on ligand 
concentration, with maximum speeds at intermediate VCAM-1 concentrations (1-2 
µg/ml corresponding to ~1150-2000 molecules/µm2, as determined by the Europium 
assay (Tong et al., 2012b)). This pattern is typical of 2D migration (DiMilla et al., 
1993). Consistent with previous reports (Goldfinger et al., 2003), CHO-α4S988A 
cells displayed the lowest migration speed over a wide spectrum of ligand 
concentrations, whereas CHO-α4Y991A cells had either a similar migration speed 
with CHO-α4WT cells at low/intermediate VCAM-1 concentrations or moved faster 
than CHO-α4WT at higher ligand concentration (≥5 µg/ml) (Fig. 2-3 A).  
As the channel width decreases (W<50 µm), cells progressively experience 
physical confinement by the lateral channel walls, and undergo deformation to 
squeeze and move through the channels (Fig. 2-2). Narrow (6 or 3 µm) channels 
induce cell contact with all 4 channel walls, and emulate migration through a 
physically constricted microenvironment (referred to as confined migration) (Balzer 
et al., 2012). In narrow channels, the migration speed of CHO-α4WT cells remained 
maximal up to intermediate VCAM-1 concentrations (0-2 µg/ml), and progressively 
decreased at higher concentrations (Fig. 2-3A). In contrast to wide (50 µm) channels, 
CHO-α4Y991A cells exhibited the lowest migration speed over a wide range of 
VCAM-1 concentrations, whereas CHO-α4S988A migrated as efficiently as CHO-
α4WT cells at low/intermediate VCAM-1 concentrations in narrow channels (Fig. 2-
3A). We also quantified migration persistence by measuring the cell chemotactic 
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index (defined as the ratio of the net displacement to the total distance traveled) and 
migration velocity (defined as net displacement divided by time). No major 
differences were noted between migration speed versus velocity because all CHO cell 
types had persistent cell motility in response to FBS (Figs. 2-3A). Because migration 
velocity represents the overall motile activity of the cells in response to a chemotactic 
stimulus, this parameter was used in the studies hereafter.  
We quantified the migratory velocity of each cell type in response to increasing 
degrees of confinement using microchannels coated with 1 µg/ml VCAM-1, because 
this concentration provided near maximal speeds of migration in both wide and 
narrow channels. CHO-α4WT cells migrated efficiently through channels of different 
widths with a migration velocity of ~30 µm/h. CHO-α4Y991A cells displayed 
progressively reduced cell motility in channels of decreasing width (Fig. 2-3B). In 
contrast, the velocity of CHO-α4S988A cells gradually increased with decreasing 
channel width (Fig. 2-3B). Similar phenomena were also observed in fibronectin-
coated (5 µg/ml) microchannels (Fig. 2-3C), thereby generalizing our observations to 
ECM proteins found in confined spaces in vivo. These data reveal the divergent 
effects of the α4 tail mutations on the migration of α4β1 integrin-expressing CHO 
cells through wide versus narrow channels. They also suggest that α4β1 integrin may 
modulate and optimize cell migration via distinct mechanisms when the cells are 
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Figure 2-3 Effects of the α4-tail mutations on cell migration in microchannels. 
(A) The migration speed and velocity of CHO-α4WT, CHO-α4Y991A and CHO-
α4S988A cells through 50-µm or 6-µm microchannels as a function of VCAM-1 
coating concentration. Data represent mean ± SEM of >20 cells from 3 independent 
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experiments. (B-C) The influence of channel width on cell migration velocity through 
microchannels coated with 1 µg/ml VCAM-1 (B) or 5 µg/ml fibronectin (C). Data 
represent mean ± SEM of >30 cells from 3 independent experiments. In (B), the 
images of migrating cells in designated channel widths and time-points are also 
shown. White arrowheads, the centroid of cell body. Bar, 60 µm. For all panels, *, P 



























α4β1 integrin regulates Rac1/myosin II crosstalk pathway 
3.1 Introduction  
      Nowadays Rho family can be categorized into five groups, Rho-like, Rac-like, 
Cdc42-like, Rnd, and RhoBTB subfamilies. Rac-like families are responsible of 
stimulating lamellipodia and membrane ruffles. Lamellipodia are the protrusive 
structures generated at the leading edge of migrating cells. Previous finding shows 
that Rac1 can play the role of activating WAVE to stimulate Arp2/3 to nucleate actin 
polymerization(Pollard, 2007). This pathway facilitates net-like actin polymerization 
and promotes protrusion activity of leading protrusion. Rho-like families are playing 
he roles of inducing stress fiber and focal adhesion formation. The Rho effector, Rho-
kinase can directly activate myosin II light chain or through inhibiting myosin light 
chain phosphatase (Gallo, 2006; Wang et al., 2009b), therefore enhancing myosin II 
contractility.  
         The crosstalk between Rho families has always been the focus of cell migration 
study. Activation of Rac has been proved to cause the inactivation of Rho and vise 
versa(Newell-Litwa and Horwitz, 2011). One of negative feedbacks from Rac1 to 
RhoA can be due to the activated p190RhoGAP(Arthur and Burridge, 2001). 
Moreover it has reported that PAK, the Rac effector can also play the role of 
inhibiting RhoA activity (Li et al., 2011). In the other hand, the high myosin II 
activity can suppress Rac1 activation (Hung et al., 2013; Lee et al., 2010).  
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      In Chapter 2, we have already described the migration phenotypes of CHO-
α4Y991A cells, where α4/paxillin binding mutation promotes Rac1-driven protrusion 
of leading edge and CHO-α4S988A cells, where α4 phosphorylation mutation 
prevent local Rac1 activation.  We speculate the α4 signaling can modulate 
Rac1/myosin II balance in different physical constraint, thus playing important role of 
regulating cell migration in response to different physical confinement. In this 
chapter, we employ immuno-fluorescence, bio-molecular method, and Rac1 
biosensor, combining with microchannel assay to investigate how α4-expressing or 
non-α4 expressing cells optimize the migration in different degree of confinement by 
modulating Rac1/myosin II signaling balance.  
3.2 Materials & Methods 
3.2.1 cell culture, pharmacological inhibitors, plasmid and transfection 
Methods of maintaining α4 expressing-CHO cells were described in Chapter 2. 
CHO cells, 3T3 fibroblasts and A375-SM cells were maintained in DMEM (high 
glucose, Life technology). Media were supplemented with 10% fetal bovine serum 
(FBS, Gibco) and 1 µg/ml penicillin/streptomycin.  For inhibitor studies using 
fibroblast-like cells, 100 µM NSC23766 (Calbiochem), 25 µM ML-7 (Sigma), 45 µM 
Y-27632 (Sigma), 50 µM blebbistatin (Cayman), 22.5 µM 6B345BBQ (Sigma) or 
appropriate vehicle controls were added to the cells seeded in serum-free medium 
near microchannel entrances. Jurkat T cells and primary CD4+ cells were treated with 
20 µM NSC23766, 75 µM blebbistatin, 90 µM 6B345TTQ or appropriate vehicle 
controls. For antibody blocking experiments, cells were treated with 3 µg/ml of anti-
α4 integrin mAb (clone P1H4, Millipore). After 1 h of incubation with the inhibitors 
or antibody at 37 oC, the chemoattractant (10% FBS) was added to topmost inlet port 
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(Fig. 2-2) to induce cell migration. Rac1-siRNA, ROCK-siRNA and control siRNA 
were from Santa Cruz Biotechnology. The RFP-PAK-PDB (in a modified pUW 
vector) was a gift from Peter Devreotes (JHU, Baltimore, MD). Transient transfection 
was performed using Lipofectamine 2000 (Life Technologies) according to the 
manufacturer’s protocol. 
3.2.2 Stress fiber imaging and quantification 
Cells were either plated on coverslips overnight or induced to migrate through 
channels of prescribed widths coated with 1 µg/ml VCAM-1. The cells were then 
fixed with 3.7% formaldehyde for 10 min, followed by permeabilization with 0.1% 
Triton X-100 for 10 min, and a 30 min blocking at room temperature (RT) with 1% 
BSA. After washing 3X with PBS, cells were incubated with Alexa568-conjugated 
phalloidin (1:500; Molecular Probes) for 1 h at RT. Images were captured at 12-bit 
depth on a Zeiss Axiovert 200 LM (Carl Zeiss) equipped with an LSM 510 META 
laser confocal scanner and a 63X/1.4 NA oil-immersion objective. For all 
acquisitions, detector voltage, scan speed, pixel resolution, laser power and optical 
zoom were standardized and utilized consistently to ensure quantitative image 
analysis. Captured images were exported as raw uncompressed TIFF images. Images 
of phalloidin-stained cells were processed using the following steps to extract the 
values of stress fiber density in ImageJ: (a) enhance intensity using default setting, (b) 
subtract the background, and (c) convert the processed image to black-and-white 
using the binary setting in ImageJ. Stress fiber area was identified as the pixels with 
value 255, distinguished from others pixels with value zero. Lastly, (d) stress fiber 
density was calculated as the percentage total cell spreading area occupied by stress 
fiber area. To obtain 3D images of actin in various degrees of confinement, the 3D 
viewer in ImageJ was used to reconstruct serial z-planes into a 3D rendering. 
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3.2.3 Focal adhesion imaging and quantification 
Cells were plated on VCAM-1-coated coverslips and allowed to spread for ~16 
h, then fixed in 3.7% formaldehyde for 10 min, permeabilized in 0.5% Triton-X 100 
for 5 min, and blocked in 2.5% BSA for 1 h. Cells were immunostained using an 
antibody against pY-paxillin (Cell Signaling) at 1:100 dilution for 2 h, followed by an 
Alexa 568 secondary antibody (Invitrogen) at 1:100 dilution for 1 h. Cells were 
washed 3 times with PBS in between each step and all steps were completed at RT. 
The stained cells were imaged by total internal reflection fluorescence (TIRF) 
microscopy using an inverted 3i Marianas microscope equipped with dual 
Photometrics Cascade II 512 EMCCD cameras for simultaneous 2-channel TIRF 
acquisition, along with a 100x/NA 1.45 oil immersion lens and Slidebook 8.0 
software. TIRF images were processed and quantified as previously described (Stroka 
and Aranda-Espinoza, 2011; Stroka et al., 2012). Briefly, images were made binary 
and the particle analyzer tool was used in ImageJ to measure PY-paxillin-positive 
punctate areas larger than 0.1 µm2, total focal adhesion area, or number of focal 
adhesions per area. Total cell area for each image was determined by tracing α4-GFP-
positive areas on TIRF images. TIRF experiments were repeated 3 times, for a total of 
40-60 cells per condition. 
3.2.4 Rac1 activity measurement by ELISA 
Cells were transfected with 1 ng/ml RFP-PAK-PDB. After 48 h of transfection, 
the cells were treated with the designated inhibitors or appropriated vehicle controls. 
Live images were taken by either broad field (inverted Eclipse Ti microscope, Nikon) 
or confocal (Zeiss Axiovert 200 LM as described above) dual-color fluorescent 
microscopy. The activated Rac1 level was quantified by averaging TRITC intensity 
normalized by averaged FITC intensity of the cells. For the α4 integrin-expressing 
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CHO cells, the FITC intensity was extracted from expression of GFP-tagged α4 
integrin. For A375, 3T3 and CHO cells, FITC intensity was extracted from 
background.  
 
3.2.5 Rac 1 activity measurement using a Rac1 probe 
The Rac1 activity was measured using the G-LISA Rac Activation Assay kit 
(Cytoskeleton). In brief, CHO-α4WT, CHO-α4Y991A, or CHO-α4S988A cells were 
plated on 1µg/ml VCAM-1 for 12 h, in the presence of select inhibitors or appropriate 
vehicle control. Cell lysates were then prepared and incubated on Rac-GTP affinity 
plates, followed by incubation with an anti-Rac1 antibody. The signal was determined 
by measuring absorbance at 600 nm using a microplate reader 
3.3 Results & Discussion 
3.3.1 Inhibition of Rac1 activation and the RhoA-myosin pathway in CHO-α4WT 
cells recapitulate the migratory phenotypes of CHO-α4S988A and CHO-α4Y991A 
cells, respectively 
The finding that α4/paxillin binding inhibits Rac1 activation (Nishiya et al., 
2005) prompted us to investigate the role of Rac1 in cell migration through channels 
of varying degrees of confinement, using the Rac1-specific small molecule inhibitor 
NSC23766 (100 µM). CHO-α4WT cells treated with NSC23766 displayed reduced 
lamellipodial protrusion relative to controls and a markedly suppressed migration 
velocity through 50-µm wide channels (Fig. 3-1A). The inhibitory effect of 
NSC23766 was progressively diminished with decreasing channel width, and was 
minimal for the migration of CHO-α4WT cells through 10-, 6- or 3- µm channels 
(Fig. 3-1A). To confirm the specificity of this intervention, we knocked down Rac1 in 
CHO-α4WT cells via RNAi, and examined the migratory potential of Rac1-depleted 
	   22	  
and scramble control cells in the microchannel assay. The efficacy of Rac1 depletion 
was verified by immunoblotting (Fig. 3-1A). Our data reveal that Rac1 knockdown 
repressed cell migration in wide, but not narrow, channels (Fig. 3-1A). Thus, 
inhibition of Rac1 activation in CHO-α4WT cells recapitulates the migratory 
phenotype of CHO-α4S988A cells in the microchannel assay. Because Rac1 can 
down-regulate myosin II via inhibition of RhoA-associated protein kinase (ROCK) or 
other mechanisms (Burridge and Wennerberg, 2004; Guilluy et al., 2011), we also 
tested the effects of the ROCK inhibitor Y-27632 (Liao et al., 2007) and myosin II 
ATPase cycle inhibitor blebbistatin (Limouze et al., 2004) on the migration velocity 
of CHO-α4-WT cells. In 50-µm channels, CHO-α4WT cells treated with Y-27632 
(45 µM) or blebbistatin (50 µM) displayed an abnormal migratory morphology 
similar to that reported by (Even-Ram et al., 2007); the trailing edge failed to retract 
to the cell body and formed a long tailed structure (Fig. 3-1A), while the leading edge 
exhibited increased lamellipodia protrusion. Neither Y-27632 nor blebbistatin 
significantly altered the migration velocity of CHO-α4WT cells in 50-, 20- or 10-µm 
channels. In contrast, these agents effectively suppressed CHO-α4WT cell migration 
in narrow (6- and 3-µm) channels relative to controls (Fig. 3-1A). Notably, ROCK1-
depleted CHO-α4WT cells displayed a similar migratory phenotype to Y-27632- or 
blebbistatin-treated CHO-α4WT cells (Fig. 3-2B). Thus, inhibition of the RhoA-
myosin II pathway in CHO-α4WT cells recapitulates the migratory phenotype of 
CHO-α4Y991A cells in the microchannel assay.  
These data show that the migration velocity of the α4β1 integrin-expressing 
CHO cells is modulated and optimized predominantly by Rac1 in wide channels, 
whereas the myosin II pathway attunes migration in narrow channels. While the 
S988A mutation may suppress wide channel migration by inhibiting Rac1 activation 
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(Goldfinger et al., 2003; Nishiya et al., 2005), we hypothesize that Y991A may 
repress narrow channel migration by enhancing Rac1 activity, which in turn 
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Figure 3-1 Effects of inhibiting Rac1, ROCK or myosin II on the migration of 
CHO-α4WT, CHO-α4Y991A, CHO-α4S988A cells in microchannels. (A) CHO-
α4WT, (B) CHO-α4Y991A, and (C) CHO-α4S988A cells were treated with either 
the Rac1 inhibitor NSC23766, the ROCK inhibitor Y-27632, the myosin II inhibitor 
blebbistatin or vehicle control, and allowed to migrate inside VCAM-1-coated 
channels. Their migration velocities in channels of different widths were quantified. 
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Data represent mean ± SEM of  >40 cells from 3 independent experiments. *, P 
<0.005 relative to control. The images of migrating cells in designated channel widths 
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Figure 3-2 .  Effects of Rac1 and ROCK-1-depletion on the migration of CHO-
α4YWT cells.  CHO-α4WT cells were transfected with Rac1 siRNA (30 nM) (A), or 
ROCK-1 siRNA (200 nM) (B) or control siRNA (Ctrl) at the corresponding 
concentrations. The depletion of Rac1 and ROCK-1 was demonstrated by 
immunoblotting using an anti-Rac1 and anti-ROCK-1 antibody, respectively.  β-actin 
served as an internal control.  The migration velocity of Rac1-, ROCK-1- depleted or 
control CHO-α4WT cells inside 50-µm and 3-µm channels was quantified.  Data 
represent mean ± SEM of >45 cells from 3 independent experiments.  *, P < 0.005 
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3.3.2 α4/paxillin binding regulates narrow channel migration through a crosstalk 
between Rac1 and myosin II. 
To test this hypothesis, we first examined if attenuation of Rac1 activity in 
CHO-α4Y991A cells alleviates the inhibitory effect of the Y991A mutation on α4β1-
regulated narrow channel migration. Indeed, the treatment of CHO-α4Y991A cells 
with the Rac1 inhibitor NSC23766 greatly enhanced narrow channel migration (Fig. 
3-1B). As expected, this intervention suppressed wide (50- and 20-µm) channel 
migration of CHO-α4Y991A cells (Fig. 3-1B). In line with prior observations 
showing that S988A mutation inhibits Rac1 activation (Goldfinger et al., 2003; 
Nishiya et al., 2005), NSC23766 treatment had little effect on the migration velocity 
of CHO-α4S988A cells through either wide (50-µm) or narrow (6- or 3-µm) channels 
compared to controls (Fig. 3-1C). In contrast to NSC23766, Y27632 and blebbistatin 
did not affect the migration of CHO-α4Y991A cells through wide or narrow channels 
(Fig. 3-1B), but reversed the migratory phenotype of CHO-α4S988A cells, by 
markedly enhancing wide channel migration and suppressing narrow channel 
migration (Fig. 3-1C). Therefore, suppression of narrow channel migration by Y991A 
mutation can be rescued by inhibiting Rac1, whereas suppression of wide channel 
migration by S988A can be rescued by inhibiting the myosin II pathway.  
 
3.3.3 Using PAK-PBD probe and ELISA assay, stress fiber and focal adhesion 
quantification to verify Rac1-myosin II crosstalk in molecular level.   
We next asked if treatment with the Rac1 inhibitor NSC23766 enhanced myosin 
II activity in CHO-α4Y991A cells. Because the assembly of stress fibers depends on 
the contractile activities of myosin II, quantifying the formation of stress fibers is a 
valid measure of myosin II-driven contractility (Chrzanowska-Wodnicka and 
Burridge, 1996). Furthermore, tyrosine-phosphorylation of paxillin (PY-paxillin) in 
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focal adhesions depends on myosin II activity (Pasapera et al., 2010) and can also be 
used to evaluate cell contractile activity. When plated on VCAM-1-coated glass 
coverslips, CHO-α4S988A cells had the highest densities of stress fibers (Fig. 3-3A-
C) and PY-paxillin-positive focal adhesions (Fig. 3-3D-F), whereas CHO-α4Y991A 
cells had the lowest. Notably, the stress fiber and focal adhesion defects in CHO-
α4Y991A cells were rescued when the cells were treated with the Rac1 inhibitor 
NSC23766 (Figs. 3-3 Ae, C and 3-3 Dd, F). On the other hand, the NSC23766 
treatment did not have any significant effect on the stress fiber density of either CHO-
α4WT or CHO-α4S988A cells. To confirm that the changes in stress fiber density 
reflect altered myosin II activity, we showed that blebbistatin significantly suppressed 
stress fiber density in CHO-α4WT and CHO-α4S988A cells (Fig. 3-3 A g, i, C). 
Moreover, blebbistatin also dramatically reduced the density of PY-paxillin-positive 
focal adhesion in CHO-α4S988A cells (Fig. 3-3 De, F). However, blebbistatin failed 
to significantly suppress the already low stress fiber density of CHO-α4Y991A cells 
(Fig. 3-3C). Similar stress fiber phenotypes were observed when the cells migrated 
inside 6-µm channels (Fig. 3-4). Under this confined condition, CHO-α4WT and 
CHO-α4S988A cells formed arrays of stress fibers that were aligned parallel to the 
channels (Fig. 3-4 a, c). In contrast, stress fibers were not detected in CHO-
α4Y991A, but this stress fiber defect was rescued by treating cells with NSC23766 
(Fig. 3-4 b, e). Blebbistatin treatment, as expected, diminished stress fibers (Fig. 3-4 
g-i). Therefore, myosin II activity is reduced when α4/paxillin binding is disrupted by 
Y991A, and this can be rescued by Rac1 inhibition.  We conclude that α4/paxillin 
binding promotes narrow channel migration by maintaining a high level of myosin II 
activity via its negative effect on Rac1. 
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We also quantified the activity of Rac1 in CHO-α4WT, CHO-α4Y991A and 
CHO-α4S988A cells using a PAK-PBD fluorescent probe (Fig. 3-5A, B) or ELISA 
(Fig. 3-5C). In both assays, Rac1 activity was the highest in CHO-α4Y991A cells, 
and it was inhibited by NSC23766. In contrast, Rac1 activity was the lowest in CHO-
α4S988A cells. Notably, it was markedly increased by blebbistatin, thereby revealing 
that the inhibitory effect of the α4S988A mutation on Rac1 and the concomitant 
migration defect in wide channels can be rescued by a negative feedback of myosin II 
to Rac1.  
Taken together, our data show that CHO-α4WT cells can migrate efficiently in 
both wide and narrow channels, but through distinct mechanisms. In wide channels, a 
high level of Rac1 activity is maintained in cells when myosin II activity is low and 
the binding between α4 integrin and paxillin is suppressed by Ser988-phosphorylation 
at the α4 tail. This allows efficient cell migration in wide channels. In contrast, in 
narrow channels myosin II activity is enhanced by α4/paxillin binding through Rac1 
inhibition, which promotes efficient migration in narrow channels. Both wide and 
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Figure 3-3 Effects of inhibiting Rac1 or myosin II on stress fiber and focal 
adhesion densities in cells migrating on 2D surfaces. CHO-α4WT, CHO-α4Y991A 
or CHO-α4S988A cells were plated on VCAM-1-coated coverslips in the presence of 
vehicle control (Aa-c, Da-c), NSC23766 (Ad-f, Dd) or blebbistatin (Ag-i, De). (A) 
Cells were stained with TRITC-conjugated phalloidin and imaged by confocal 
microscopy. (B-C) Stress fiber density was measured and graphed as percentage total 
cell area occupied by stress fibers in the absence (B) or presence of NSC23766 (NSC) 
or blebbistatin (Bleb) (C). Data represent mean ± SEM of 40 cells from 3 independent 
experiments. *, P <0.05 relative to control. (D) Cells were stained with an antibody 
against pY-paxillin and imaged by TIRF microscopy. (E-F) Focal adhesion density 
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was measured as the number of focal adhesions per µm2 in the absence (E) or 
presence of NSC23766 (NSC) for CHO-α4Y991A or blebbistatin (Bleb) for CHO-
α4S988A cells (F). Data represent mean ± SEM of 45 cells from 3 independent 
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Figure 3-4 Effects of inhibiting Rac1 or myosin II on stress fiber and focal 
adhesion densities in cells migrating inside 6-µm channels. CHO-α4WT, CHO-
α4Y991A, and CHO-α4Y988A cells were induced to migrate inside 6-µm VCAM-1-
coated channels in the presence of vehicle control (a-c), NSC23766 (d-f) or 
blebbistatin (g-i). Cells were stained with TRITC-conjugated phalloidin and imaged 
by confocal microscopy. The box at the lower left corner of each panel shows an 
enlarged view highlighting the stress fibers. Bar, 10 µm. 
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Figure 3-5 Effects of Rac1 or myosin II inhibitors on Rac1 activity. (A) CHO-
α4WT, CHO-α4Y991A and CHO-α4S988A cells transfected with RFP-PAK-PBD 
were plated on VCAM-1 and imaged for GTP-loaded Rac1 (red) and GFP-tagged α4 
integrin (green) by dual-color confocal microscopy in presence of vehicle control, 
NSC23766 for CHO-α4Y991A or blebbistatin for CHO-α4S988A. Bar, 45 µm. (B) 
Rac1 activity was quantified by measuring the RFP-PAK-PBD red fluorescence 
intensity for each cell type normalized by GFP-tagged α4 integrin. Data represent 
mean ± SEM of ≥50 cells from 2 independent experiments. (C) The overall level of 
GTP-loaded Rac1 was quantified in presence of vehicle control or indicated 
treatments using ELISA. Data represent mean ± SEM from 4 independent 
experiments. *, P <0.05.   
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3.3.4 α4β1-mediated signaling pathway is required for the migration of invasive 
melanoma cells 
α4β1 integrin is upregulated in human primary invasive melanoma cells 
(Mostafavi-Pour et al., 2003; Ryu et al., 2007) and plays important roles in melanoma 
extravasation (Matsuura et al., 1996). Therefore, we tested an invasive melanoma cell 
line, A375-SM, which expresses high levels of endogenous α4β1 integrin. Like CHO-
α4WT, A375-SM cells displayed a fibroblast-like morphology on VCAM-1- or 
fibronectin-coated surfaces. Moreover, A375-SM cells exhibited a similar dependence 
of migration velocity on VCAM-1 concentration as the α4β1-expressing CHO cells in 
wide and narrow channels (Fig. 2-3A, 3-6A). In VCAM-1- or fibronectin-coated 
microchannel, NSC23766 treatment suppressed wide (50- and 20-µm) channel 
migration but enhanced narrow (6- and 3-µm) channel migration (Fig. 3-6 B, E). In 
contrast, blebbistatin inhibited narrow channel migration without altering the 
migration velocity through wide channels (Fig. 3-6 B, E). Of note, blebbistatin-
treated A375-SM cells displayed lamellipodia protrusion and trailing tail defects 
similar to those observed in blebbistatin-treated CHO-α4WT cells. NSC23766 
treatment increased the stress fiber density of cells plated on a 2D surface (Fig. 3-6 C) 
and resulted in thicker stress fibers in cells migrating through 6-µm channels (Fig. 3-
6D). As expected, blebbistatin diminished stress fiber formation (Fig. 3-6 C, D). 
Thus, high stress fiber levels correlate with high cell migration potential in narrow 
channels, which is consistent with the data on CHO-α4WT cells.  
We next tested the pharmacological inhibitor 6B345TTQ, which specifically 
disrupts α4/paxillin binding (Kummer et al., 2010). Similar to CHO-α4Y991A cells, 
treatment of A375-SM cells with 6B345TTQ increased migration velocity in wide 
channels but suppressed it in narrow channels (Fig. 3-6F). Notably, these effects were 
	   35	  
abolished when A375-SM cells were co-treated with 6B345TTQ and NSC23766 (Fig. 
3-6F). NSC23766 also reversed the 6B345TTQ-induced suppression of stress fiber 
formation (Fig. 3-6D). These results demonstrate that the signaling pathway involving 
α4/paxillin binding and the crosstalk between Rac1 and myosin II is required for 
efficient migration of A375-SM cells in narrow channels.  
We also treated A375-SM cells with an anti-α4 integrin blocking antibody. 
This treatment markedly reduced the migration velocity in both wide and narrow 
channels (Fig. 3-7A). Blebbistatin and NSC23766 rescued the migratory defect 
induced by the anti-α4 integrin antibody in wide and narrow channels, respectively 
(Fig. 3-7A). Furthermore, blebbistatin and NSC23766 increased the Rac1 activity and 
stress fibers, respectively, in anti-α4 integrin-treated A375-SM cells (Fig. 3-7 D, E). 
These results disclose the importance of α4β1 integrin in promoting the migration of 
A375-SM cells in both unconfined and confined spaces.  Like CHO-α4WT cells, 
A375-SM cells optimize their motile activities by routing the α4β1-mediated 
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Figure 3-6 Migration of A375-SM cells in microchannels. A375-SM cells were 
induced to migrate in microchannels coated with VCAM-1 (A-D) or fibronectin (E-
F). (A) Migration velocity of A375-SM cells as a function of VCAM-1 coating 
concentration in 50-µm and 6-µm microchannels. (B and E) A375-SM cells were 
treated with NSC23766, blebbistatin or vehicle control, and their migration velocities 
in channels of different widths were quantified. In (B), the images of cells migrating 
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inside the 50-µm or 6-µm channels at designated time-points are shown. White 
arrowheads, the centroid of cell body. Bar, 60 µm. (C-D) A375-SM cells were plated 
on a 2D surface (C) or induced to migrate inside a 6-µm channel (D) in the presence 
of vehicle control, NSC23766 or blebbistatin, stained with TRITC-conjugated 
phalloidin and imaged by confocal microscopy. The box at the lower left corner of 
each panel shows an enlarged image of stress fibers. Bars, 20 µm. In (C), the density 
of stress fibers was measured and graphed as percentage of total cell spreading area 
occupied by stress fibers. Each data (A-E) represent mean ± SEM of >40 cells from 3 
independent experiments. *, P <0.005 (B, E) or P <0.05 (C). (F) A375-SM cells were 
treated with the α4/paxillin binding inhibitor, 6B345TTQ, in the presence of 
NSC23766 or vehicle control. Cell migration velocities in channels of different 
widths were quantified. Data represent mean ± SEM of  >30 cells from 2 independent 
experiments for each channel width. *, P <0.005 relative to control. §, P <0.005 
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Figure 3-7 Effects of Rac1 and myosin II inhibitors on the migration of A375-
SM, CHO cells and 3T3 fibroblasts in microchannels. A375-SM cells treated with 
an anti-α4 integrin antibody or an isotype control (A), CHO cells (B) or 3T3 
fibroblasts (C) were incubated with with NSC23766, blebbistatin or the vehicle 
control and allowed to migrate through microchannels coated with fibronectin. Cell 
migration velocities in channels of different widths were quantified. CHO-α4WT 
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cells treated with vehicle control were also included for comparison (B). Data 
represent mean ± SEM of >30 cells from at least 3 independent experiments for each 
channel width. *, P <0.005 relative to control. (D) Cells migrating inside 6 µm 
channels were stained with TRITC-conjugated phalloidin and imaged by confocal 
microscopy. The box at the lower left corner of each panel shows an enlarged image 
of stress fibers. Bars, 20 µm. (E) Rac1 activity was quantified by measuring the RFP-
PAK-PBD red fluorescence intensity for each cell type normalized by FITC intensity 
from background using dual-color broad field microscopy. Data represent mean ± 
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3.3.5 The migration of CHO cell and 3T3 fibroblast in wide and narrow channels is 
attenuated by myosin II and Rac1, respectively 
The results from the anti-α4 integrin antibody experiments (Fig. 3-7 A, D, E) 
suggest that the rescue by NSC23766 and blebbistatin in the microchannels could be a 
general phenomenon for fibroblast-like cells that are devoid of α4β1 integrin. To test 
this, we assessed the migratory potential of parental CHO cells and 3T3 fibroblasts in 
the microchannel assay in the presence and absence of NSC23766 or blebbistatin. In 
line with anti-α4 integrin-treated A375-SM cells, the parental CHO cells displayed a 
reduced migration velocity compared to CHO-α4WT cells in fibronectin-coated wide 
and narrow channels; Blebbistatin and NSC23766 increased CHO cell migration 
velocity in wide and narrow channels, respectively (Fig. 3-7B). Moreover, 
blebbistatin and NSC23766 increased Rac1 activity and stress fiber density of CHO 
cells, respectively (Fig. 3-7D, E). Similar observations were made with 3T3 
fibroblasts (Fig. 3-7 C, D, E). These data demonstrate that, in fibroblasts, myosin II 
and Rac1 can function as breaks through a crosstalk mechanism to attenuate the 















Myosin II A and Myosin II B differentially regulate confined 
and unconfined migration 
4.1 Introduction  
      The myosin superfamily of actin-based molecular motors consists of at least 25 
different classes. The myosin II subfamily, which includes skeletal, cardiac and 
smooth muscle myosins, as well as nonmuscle myosin II (NMII), has the most 
members. In vertebrates, there are over 15 different myosin II isoforms, each of which 
contains a different myosin II heavy chain (MHC). This MHC diversity is generated 
by multiple genes as well as by alternative splicing of the pre-mRNA that encodes 
them. 
          Myosin II molecules are hexamers composed of MHC dimers and two pairs of 
myosin light chains (MLCs), and can bind reversibly to actin filaments, hydrolyze 
ATP in a process that is activated by actin and thereby convert chemical energy into 
mechanical force and movement. Although this contractile activity is most evident in 
differentiated muscle tissues, such as the beating heart, it is also seen in nonmuscle 
cells in diverse cellular processes such as cell division, cell migration, and cell-cell 
and cell-matrix adhesion. There is, however, a fundamental difference in regulation 
within the vertebrate myosin II subclass. Whereas the primary regulation of skeletal 
and cardiac muscle myosin II is through a set of actin-associated proteins – troponin 
and tropomyosin – the regulation of vertebrate nonmuscle and smooth muscle myosin 
II is through phosphorylation of the 20 kDa MLC(Vicente-Manzanares et al., 2009). 
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This latter type of regulation permits nonmuscle and developing muscle cells to 
respond to numerous signals originating both outside and inside the cell. 
      Whereas the N-terminal globular head of the molecule contains the MgATPase 
catalytic domain, the α-helical coiled-coil Cterminal domain is involved in filament 
formation. Thus, myosin can be viewed as a bipartite molecule that has two distinct 
but related functions. One is manifested by its ability to translocate actin filaments 
and resides in its globular motor domain and lever arm. This ability to act as a motor 
permits a number of different roles. For example, myosin plays a role in cell 
migration both by moving the body of the cell forward and by retracting the rear of 
the cell, and it can redistribute inside cells, thus playing a role in generating cell 
polarity. The second function of NMII is structural and resides in the ability of the rod 
portion of the molecule to form filaments, which allows several myosin heads to 
maintain tension for long periods of time, similarly to smooth muscle myosin. Both 
functions require binding to actin. The recent availability of mutant forms of NMII 
with compromised motor activity has permitted separation of these functions in both 
cultured cells and mice. 
           In general, NMII provides contractility in cell migration and this process is 
facilitated by phosphorylation of myosin light chain (MLC). It has reported that 
several kinases catalyze this phosphorylation. Myosin light chain kinase and Calcium 
interaction together activate MLCK, which in turn promotes phosphorylation of 
MLC. However, Rho kinase can phosphorylate MLC via activating MLCK itself or 
by inhibiting the subunit of myosin phosphatase (Wilkinson et al., 2005).  Moreover, 
some researches have shown that MLCK and Rho kinase activate MLC in spatial 
regulation. MLCK regulates MLC in cell periphery and in contrast Rho kinase is 
more active in cell center, where focal adhesion formation is regulated(Totsukawa et 
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al., 2000). Moreover, Rho kinase preferentially regulates the phosphorylation of MIIA 
myosin light chian in cell center, which implies that difference kinase(Totsukawa et 
al., 2000) might have differential regulation of myosin II iso-forms (Sandquist et al., 
2006). Accumulated evidence show that MIIA and MIIB function differentially 
during cell migration (Even-Ram et al., 2007; Kolega, 2006; Vicente-Manzanares et 
al., 2007). More researches have indicated that the primary role of MIIA is to provide 
contractile force, but not exclusively, MIIB is more responsible of generating the 
force of lamellipodia ruffle in cell leading edge (Giannone et al., 2007).    
      Because of the critical roles of myosin II in cell migration, in this chapter, using 
our microchannel assay, we sought to investigate the differential roles of MIIA and 
MIIB in response to different degree of physical confinement.  
 
4.2 Materials & Methods 
4.2.1	  Myosin	  II	  A	  and	  Myosin	  II	  B	  plasmid	  and	  transfection	  
The pSUPER-MIIA, pSUPER-MIIB, siRNA-insensitive MIIA and MIIB were 
gifts from Alan F. Horwitz (University of Virginia, Chalottesville, VA). In pSUPER-
MIIA and pSUPER-MIIB, the oligonucleotides G A T C T G A A C T C CT T C G A 
G C (IIA) and G G A T C G C T A C T A T T C A G G A (IIB) were inserted into the 
appropriate pSUPER cassette. In siRNA-insensitive MIIA and MIIB plasmids, MIIA 
and MIIB cDNA, each carrying a silent mutation, were inserted into an mCherry 
vector modified from pEGFP-C1 (Vicente-Manzanares et al., 2007). The RFP-PAK-
PDB (in a modified pUW vector) was a gift from Peter Devreotes (JHU, Baltimore, 
MD). Transient transfection was performed using Lipofectamine 2000 (Life 
Technologies) according to the manufacturer’s protocol. Knockdown efficiency was 
verified by Western blotting analysis using antibodies against MIIA (Sigma), MIIB 
(Santa Cruz Biotechnology) and β-actin (Sigma).  
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4.3 Results & Discussion 
4.3 MIIA and MIIB have distinct roles in wide versus narrow channel migration 
The differential effects of blebbistatin on wide versus narrow channel migration 
prompted us to examine the relative contributions of non-muscle myosin II isoforms 
to cell migration through these microchannels. The major non-muscle myosin II 
isoforms, IIA (MIIA) and IIB (MIIB), share the basic ATPase-dependent motor 
functions of binding and contracting F-actin, but they have distinct enzymatic kinetics 
(Kelley et al., 1996), subcellular distributions (Cai et al., 2006; Kelley et al., 1996) 
and functions (Stroka and Aranda-Espinoza, 2011). We knocked down each isoform 
in CHO-α4WT cells by transiently expressing MIIA- or MIIB-siRNA in the cells. 
The efficacy of MIIA or MIIB depletion was verified by immunoblotting (Fig. 4-1A). 
MIIA-depleted CHO-α4WT cells exhibited increased lamellipodia protrusion and a 
trailing tail phenotype (Fig. 4-1B) similar to that displayed by MIIA-depleted 
fibroblasts (Doyle et al., 2009; Even-Ram et al., 2007) and blebbistatin- and Y27632-
treated CHO-α4WT cells (Fig. 2-3). Like the blebbistatin and Y27632 treatments, 
MIIA depletion in CHO-α4WT cells failed to alter wide (50- and 20-µm) channel 
migration but markedly suppressed narrow (6- and 3-µm) channel migration (Figs. 4-
1B and 4-2). In distinct contrast, MIIB-depleted CHO-α4WT cells exhibited poor 
spreading (Figs. 4-1 and 4-2), resulting in a dramatic reduction of wide channel 
migration (Fig. 4-1B), whereas the inhibitory effect became less pronounced as the 
channel width decreased (P>0.06 at 6- and 3-µm channels). Furthermore, the 
inhibitory effects of MIIA- or MIIB-siRNA were rescued by co-transfection of 
siRNA-insensitive MIIA or MIIB, respectively (Fig. 4-2). Thus, while depleting 
MIIA had similar effects as blebbistatin and Y23766, depleting MIIB displayed 
similar effects as the Rac1 inhibitor NSC27632.   
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Both MIIA and MIIB are activated by myosin light chain kinase (MLCK). We 
therefore tested the effect of blocking MLCK by treating cells with a specific MLCK 
inhibitor, ML-7 (25 µM). This intervention suppressed cell spreading and inhibited 
CHO-α4WT cell migration in both wide and narrow channels (Fig. 4-1C).  
Collectively, our data reveal that MIIA and MIIB have distinct roles in wide 
versus narrow channel migration. MIIA is required for narrow channel migration and 
MIIB for wide channel migration, whereas MLCK is required for both wide and 
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Figure 4-1 Effects of MIIA- or MIIB-depletion on the migration of CHO-α4WT 
cells in microchannels. (A) CHO-α4WT cells were either transfected with an siRNA 
for MIIA (a) or MIIB (b) or a control siRNA (Ctrl), or with lipofectamine only (LF) 
or remained untransfected (non). The depletion of either MIIA or MIIB by their 
corresponding siRNAs was demonstrated by immunoblotting using an anti-MIIA or 
anti-MIIB antibody. β-actin served as an internal control. (B) The migration velocities 
of MIIA-, MIIB-depleted CHO-α4WT cells and siRNA controls were quantified as a 
function of channel width. (C) The migration velocity of CHO-α4WT cells, treated 
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with either ML-7 or a vehicle control, was measured in channels of different widths. 
In (B) and (C), all channels were coated with VCAM-1.  Data represent mean ± SEM 
of  >45 cells from 3 independent experiments. *, P <0.005. The images of cells 
migrating inside 50-µm or 6-µm microchannels at designated time-points are also 
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Figure 4-2 Rescue of migration defect of MIIA- or MIIB-depletion by 
cotransfection with mChe-MIIA or mChe-MIIB in CHO-α4WT cells. Cells were 
transfected with either MIIA siRNA (60 nM) or scramble control or co-transfected 
with MIIA siRNA and mCherry-MIIA (1 ng/ml) (60 nM) (A). Similarly, cells were 
transfected with MIIB siRNA (60 nM) or scramble control or co-transfected with 
MIIA siRNA and mCherry-MIIB (1 ng/ml) (60nM) (B). The depletion and rescue of 
MIIA and MIIB were confirmed by the absence or presence of stress fibers visualized 
by immunofluorescent staining with antibodies against MIIA (Aa and b) or MIIB (Ba 
and b), or by the fluorescence of mCherry (Ac and d for MIIA; Bc and d for MIIB). 
The migration velocity of MIIA-, MIIB-depleted, and MIIA, MIIB-rescued or 
scramble control CHO-α4WT cells inside microchannels of different widths was 
quantified. Data represent mean ± SEM of >25 cells from ≥2 independent 
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experiments. *, P < 0.005 relative to a control siRNA. §, P< 0.005 relative to 































Confined migration of α4β1 expressing T-cells is regulated 
by Rac1/myosin II pathway  
5.1 Introduction  
      Leukocytes are highly migratory cells that can develop a spectrum of versatile 
migration strategies to enter and transmigrate through various tissues and 
organs(Friedl and Brocker, 2000; Hauzenberger et al., 1995; Springer, 1994). In the 
body, migrating leukocytes adapt their cell bodies to preexisting structures, yet appear 
simultaneously able to structurally modify matrix barriers. Putatively nondestructive 
T cell migration occurs within the loose connective tissue of lymphatic organs and 
interstitial compartments(Hauzenberger et al., 1995). These compartments comprise 
the lymph node cortex, the mesentery, perivascular fibrillar trails along blood vessels, 
or the dermal papillae(Friedl et al., 1998; Hauzenberger et al., 1995). It has been well 
studied that to reach inflammatory side, T lymphocytes perform crawling along the 
surface of other cells, such as vessel endothelium before transmigration, fibroblastic 
reticulum cells in lymph nodes (Gretz et al., 1997), and antigen-presenting 
cells(Gunzer et al., 2000). For both cancer cells and T lymphocytes, the infiltration of 
basement membranes requires attachment integrated with proteolytic 
mechanisms(Leppert et al., 1995) and profound shape changes. In chronic 
inflammation, the interaction of T cells with resident tissue cells can result in severe 
proteolytic remodeling of tissue architecture, integrity, and function(Mach et al., 
1999). For all of these conditions, migratory traction occurs in conjunction with 
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recognition of additional activation signals from the counterpart cell or matrix 
interphase, implicating overlapping pathways of cytoskeletal dynamics and signal 
transduction. Such a broad spectrum of migratory capabilities through or across 
biophysically and biochemically very different substrates implies a great degree of 
flexibility and adaptability of leukocyte migration and positioning strategies. Such 
diversity may set leukocytes apart from other more specialized migratory cell types. 
As examples, fibroblasts, keratinocytes, and neurons migrate only under 
circumstances highly restricted in location and time, i.e., on morphogenesis or wound 
healing within a specific tissue context. 
       Cell migration within the tissues is a complex mechanochemical process that 
requires the integration of key events in signaling, cytoskeletal, membrane, and 
adhesion systems. Based on cell type-specific morphological and functional criteria of 
migration within an extracellular matrix (ECM) environment, i.e., polarization and 
shape change, migration velocity, cytoskeletal organization, and integrin and protease 
expression and function, at least three migratory prototypes can be classified: (1) 
amoeboid crawling can be distinguished from (2) fibroblast-like, mesenchymal 
migration and collective cell movement, as seen in multicellular strands, sheets, or 
clusters. 
        The concept of amoeboid movement is most clearly established by studies using 
the single-cell stage of the lower eukaryotic ameba Dictyostelium discoideum(Mach 
et al., 1999). Amoeboid movement results from alternating cycles of morphological 
expansion and contraction driven by cytoskeletal dynamics, shape change where less 
stress fiber formation/focal adhesion is required. Amoeboid migration allows to 
rapidly adapt especially 3D environment in order to develop high migration velocities 
transmigrating physiological barriers. Moreover this featured movement has been 
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observed in higher eukaryotes, most notably for neutrophils, lymphocytes, and some 
tumor cells(Springer, 1994; Stossel, 1994). 
        α4β1 integrin are important adhesion/migration molecules of T-cells that confer 
mechanical stability on interactions between cells and their environment. The well-
known function of α4β1 of T-cells is its adhesive function to vascular-cell adhesion 
molecule 1 (VCAM-1) and mucosal addessin-cell adhesion molecule 1 (MAdCAM-
1). It has been well established that molecular interaction is critical for T-cells to 
traffic in central nervous system and intestine. In contrast, the accumulated evidence 
shows that in CNS micro-vessel where the diameter is limited to several microns and 
fluid speed is reduced, T-cell employs α4β1 signaling to trigger amoeboid migration 
to fast move along those micro-vessel (von Andrian and Engelhardt, 2003).    
         In this chapter, inheriting the concept of featured confined migration mode in 
fibroblast-like cells, using microchannel assay, we sought to reveal the α4β1-
mediated mechanistic switch between amoeboid and fibroblast-like, mesenchymal 
migration in Jurkat T-cell and CD4+ T cells isolated from mice.  
  
5.2 Materials & Methods 
5.2.1 Jurkat T-cell culture 
Jurkat T cells and primary CD4+ cells were treated with 20 µM NSC23766, 75 
µM blebbistatin, 90 µM 6B345TTQ or appropriate vehicle controls. For antibody 
blocking experiments, cells were treated with 3 µg/ml of anti-α4 integrin mAb (clone 
P1H4, Millipore). After 1 h of incubation with the inhibitors or antibody at 37 oC, the 
chemoattractant (10% FBS) was added to topmost inlet port 
5.2.2 T-cell isolation 
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Mice were kept in accordance with guidelines of the Johns Hopkins University 
Institutional Animal Care and Use Committee. α4Y991A mice carrying a targeted 
α4Y991A mutation, backcrossed into a C57BL/6 background, were a gift from Mark 
H. Ginsberg (Feral et al., 2006). Wild-type C57BL/6 mice were obtained from 
Jackson Laboratories. The mice were sacrificed via CO2 asphyxiation. Spleens and 
lymph nodes were collected and homogenized, and red blood cells were lysed. CD4+ 
T cells were purified using Miltenyi magnetically labeled beads (Miltenyi Biotec) 
according to the manufacturer’s protocol. Cells were then cultured in 50% RPMI/50% 
EHAA media supplemented with 10% heat-inactivated low-LPS FBS, 1% 
penicillin/streptomycin, and 1% glutamine and stimulated with plate-bound anti-CD3 
(145-2C11) in combination with anti-CD28 (2 µg/ml) antibodies for 72 h (Fig 5-1). 
5.3 Results & Discussion 
The migration of T lymphocyte is promoted by α4/paxillin binding and the 
downstream Rac1-myosin II crosstalk pathway 
α4β1-integrin is highly expressed in T lymphocytes (Yednock et al., 1992). T 
lymphocytes display an amoeboidal mode of migration, which is distinct from that of 
fibroblast-like cells such as α4β1 integrin-expressing CHO and A375-SM melanoma 
cells. We thus sought to investigate the migratory phenotype of the Jurkat T cell line 
and primary T cells. Reminiscent to CHO-α4WT and A375-SM cells migrating in 
narrow channels, the migration velocity of Jurkat T cells was suppressed by 
blebbistatin but was enhanced by NSC23766, albeit in all channels (Fig. 5-2A). The 
migratory potential of T cells on 2D is negatively correlated with their spreading area 
(Jacobelli et al., 2010). Thus, we also measured this parameter. Blebbistatin and 
NSC23766 increased and reduced, respectively, the spreading area of Jurkat T cells 
on VCAM-1-coated 2D surfaces (Fig. 5-2D). To determine if α4/paxillin binding 
contributes to Jurkat T cell migration, cells were treated with 6B345TTQ (22.5 µM), 
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which specifically disrupts α4/paxillin binding. 6B345TTQ significantly reduced the 
migration of Jurkat T cells in all channels and increased their spreading area (Fig. 5-
2B, E), which is in line with published data on 2D (Kummer et al., 2010). 
Furthermore, co-treatment with 6B345TTQ and NSC23766 abolished the effect of 
6B345TTQ on the migration velocity and cell spreading (Fig. 5-2B, E). 
We also tested primary CD4+ T cells isolated from mice carrying the α4Y991A 
mutation generated by gene targeting (Feral et al., 2006) (referred as to α4Y991A-
CD4+), and those from wild-type mice (referred as to WT-CD4+). α4Y991A-CD4+ 
cells exhibited larger spreading area when plated on 2D surface and reduced 
migration velocities relative to WT-CD4+ in all channels (Fig. 5-2C, F), which is in 
concert with the reported spreading and 2D migration phenotypes of Jurkat T cells 
carrying the α4Y991A mutation (Liu et al., 1999). Notably, the migration and 
spreading defects of α4Y991A-CD4+ cells were rescued by NSC23766 (Fig. 5-2C, 
F). We thus conclude that α4/paxillin binding and its inhibitory effect on Rac1 
promotes effective migration of T cells via Rac1-myosin II crosstalk, which is 
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Figure 5-1 Procedures of isolating T-cell  
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Figure 5-2 Effects of Rac 1 and myosin II inhibitors on the migration of Jurkat T 
and primary CD4+ T cells in microchannels. (A, D) Jurkat T cells were treated with 
NSC23766 (NSC) or blebbistatin (Bleb) or vehicle control (Ctrl). (B, E) Jurkat T cells 
were treated with the α4/paxillin binding inhibitor, 6B345TTQ, or vehicle control, or 
6B345TTQ plus NSC23766 or vehicle control. (C, F) Primary WT-CD4+ or Y991A-
CD4+ T cells were treated with vehicle control or NSC23766.  Cells were either 
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induced to migrate through channels of different widths (A-C) or plated on a 2D 
surface (D-E). All surfaces were coated with VCAM-1. Cell migration velocities (A-
C) and mean spreading areas (D-E) were quantified. Data represent mean ± SEM of 
>60 cells. *, P < 0.005 relative to control (A, B) or WT-CD4+ T cells (C). §, P <0.005 




























Cell modulates protein kinase A activity to optimize 
confined/unconfined migration  
6.1 Introduction  
Cell migration in response to growth factors and chemoattractants is essential for 
embryonic development, tissue homeostasis, and the immune response(Knight et al., 
2000). It is also a major factor in the pathogenesis of many human diseases, including 
cancer(Stetler-Stevenson et al., 1993). This complex process involves dynamic and 
coordinated interactions among integrins, chemoattractant receptors, and the actin 
cytoskeleton, which result in actin polymerization at the leading edge and contraction 
of actin bundles within the cell body to promote translocation. These dynamic 
changes in the actin cytoskeleton are initiated by the engagement of chemoattractant 
and integrin receptors on the cell surface with the respective ligands. Such 
interactions trigger cascades of outside-in signaling that results in the remodeling of 
the actin cytoskeleton and consequent directed movement(Liu et al., 1999; Moyano et 
al., 2003; Nishiwaki et al., 2000; Urbano et al., 2011). To understand the mechanism 
of cell migration in different physical environemnt, these signaling events need to be 
defined and linked to cell surface receptors, actin dynamics, and local geometry. 
Members of the Rho family of GTPases, including Rho/myosin II pathway, Rac1, 
Cdc42, Arp2/3 complex, and Wiskott-Aldrish syndrome protein (WAVEs) are 
considered to be key signaling intermediates for cell migration as discussed in 
previous chapters.  
	   59	  
 
Recent studies have highlighted an important role for cAMP/PKA metabolism in the 
migration of carcinoma cells and in the regulation of RhoA and Rac1 function in 
several cooperative pathways (Backert et al., 2010; Brandt et al., 2009; Newell-Litwa 
and Horwitz, 2011; Zimmerman et al., 2012). For example, α4 integrin expressing in 
wide variety of cell line such as fibroblast-like melanoma and leukocytes plays very 
important role of enhancing the cell migration in different degree of confinement and 
various physical constraint. It has reported that the phosphorylation of the α4 
cytoplasmic domain by c-AMP–dependent protein kinase A (PKA) inhibits paxillin 
binding and is restricted to the leading edge of broad protrusive lamellipodia(Liu et 
al., 1999; Nishiya et al., 2005). This localized phosphorylation of α4 at the leading 
edge is critical for optimize α4β1-mediated 2D migration(Goldfinger et al., 2003). 
However, we have found that when cell encounters physical constraint, α4β1 integrin 
could optimize confinement migration by up-regulating RhoA/myosin II pathway. 
However, the how confined cells receive the signal from upstream sensor to regulate 
this process still remains unknown.  
The spatiotemporal PKA activity plays an important role of variety of cellular 
processes, such as survival, proliferation, and migration. PKA phosphorylates 
numerous protein substrates such as ion channels, GTPases, and transcription factors. 
The substrate specificity of PKA in vivo is controlled by its subcellular 
compartmentalization and is mediated by interactions of its regulatory subunits with 
A-kinase anchoring proteins (AKAPs). For example, Arp2/3 stimulating actin 
branching is recruited by an AKAP, WAVE, which also provides an anchor site for 
PKA to associate, thus enriching cell protrusion in several cell types. Moreover, α4 
cytoplasmic tail also serves as an AKAP and α4 phosphorylation results in Rac1 
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activation. Therefore, the interplay of local activated PKA, α4 phosphoryaltion, and 
AKAPs accessibility in response to physical constraint together determines the 
migration efficiency.  
 In this Chapter, we have developed Förster resonance energy transfer (FRET)-based 
PKA kinase activity reporters that permit the real-time measurement of bulk PKA 
activity in the cytoplasm of a living cell. Here, we specifically examine the 
localization of PKA activity at the plasma membrane of living cells using a 
membrane-targeted reporter, AKAR4-Kras. We showed that cell locally and 
integratedly modulates its membrane-PKA activity in response to different physical 
constraint.   
 
6.2 Materials & Methods 
6.2.1 cell culture and treatments 
CHO-α4WT were generated by stably transfecting CHO cells with pQN4G plasmids, 
in which wild-type or mutant α4 integrin cDNA was inserted into a PGBI25-fN1 GFP 
vector (Dikeman et al., 2008; Pinco et al., 2002). The cells were maintained in Ham’s 
F12 (Cellgro, 10-080-CM, company) medium. CHO cells were maintained in DMEM 
(high glucose, Life technology). Media were supplemented with 10% fetal bovine 
serum (FBS, Gibco) and 1 µg/ml penicillin/streptomycin.  For inhibitor studies, 50 
µM forskolin (Santa Cruz), 50 µM Rp-cAMPs (Santa Cruz), or appropriate vehicle 
controls were added to the cells seeded in serum-free medium near microchannel 
entrances. Transient transfection was performed using Lipofectamine 2000 (Life 
Technologies) according to the manufacturer’s protocol. 
 
	   61	  
6.2.2 PKA biosensor transfection and imaging 
         Cells were washed twice with Hanks’ balanced salt solution buffer and 
maintained in the dark at room temperature. Cells were imaged on a Zeiss Axiovert 
200M microscope with a cooled charge-coupled device camera (MicroMAX BFT512, 
Roper Scientific, Trenton, NJ) controlled by METAFLUOR 6.2 software (Universal 
Imaging, Downingtown, PA). Dual cyan/yellow emission ratio imaging used a 
420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission filters 
[475DF40 for CFP and 535DF25 for YFP]. These filters were alternated by a filter-
changer Lambda 10–2(Sutter Instruments, Novato, CA). Exposure time was 50–500 
ms, and images were taken every 10–30 s.  Fluorescence images were background-
corrected by subtracting the fluorescence intensity of background with no cells from 
the emission intensities of cells expressing fluorescent reporters. The ratios of 
yellow/cyan emissions were then calculated at different time points. The values of all 
time courses were normalized by dividing each by the average basal value before drug 
addition. 
6.2.3 1D patterning 
A custom mask with 8µm wide linear line was generated using Adobe Illustrator 
(Adobe), printed on a transparency at high resolution (Pageworks) and used to 
generate master mold. The general procedure using silicon mold to make PDMS 
stamp is similar to the protocol of PDMS micro-fluidic in Chapter 2, Materials and 
Methods. Stamps were then cut out and sonicated in ethanol before each use. Stamps 
were dried under a nitrogen stream and then coated with a 50mg/ml solution of 
fibronectin for 30 minutes. To check patterning, stamps were occasionally coated with 
a mixture of 50 mg/ml fibronectin, rabbit polyclonal anti-fibronectin antibody 
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(Calbiochem, Gibbstown, NJ) at 1:10 dilution, and Alexa Fluor 488 goat anti-rabbit 
secondary antibody at 1:100 dilution. Before stamping, 35-mm glass bottom dishes 
were cleaned with ethanol and oxygen plasma. Dishes were stamped with fibronectin 
for 1 minute, heated to 140̊C for 30 seconds (Fink et al., 2007), and passivated with 
0.1 mg/ml PLL(20)-g-[3,5]-PEG(2) (Susos AG, Dubendorf, Switzerland) in 10 mM 
HEPES (pH 7.4) for 30 minutes to render the unstamped regions of the dish resistant 
to cell adhesion (Thery and Piel, 2009). Plates were then washed in PBS and stored at 
4̊C for up to 2 weeks or immediately used for cell seeding. Stamps were cleaned with 
Scotch tape (3M, St Paul, MN) after use. 
  
6.3 Results & Discussion 
6.3.1 CHO-α4WT cells reduced α4 phosphorylation level in confined migration 
 The finding that both CHO-α4WT cells and CHO-α4S988A migrating through 
narrow channels (6-µm and 3-µm in width) displayed optimal motility suggests that 
α4 phosphotylation level is reduced to optimize confined migration. To investigate 
the phosphorylation level of α4 in response to physical confinement, we applied 
novel microchannel assay. In this assay, cells were first seed in the 2D seeding area 
and then allowed to migrate toward chemoattractant source through fibronectin-
coated channels of fixed height (10µm) and length (200µm) but variable widths 
(20µm, 10µm, 6µm, and 3µm) (Fig. 6-1A). Migrating cells expressing GFP-tagged 
α4 were fixed and stained with antibody against phosphorylated α4 integrin and 
imaged by confocal microcopy. Unconfined CHO-α4WT cells demonstrate highest 
α4 phosphorylation level, however the α4 phosphorylation level was gradually 
reduced as degree of confinement increases (Fig. 6-1B). Cells migrating in narrow 
channels (6µm and 3µm in width) display bipolar α4 phosphorylation pattern and the 
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α4 phosphorylation level was significantly reduced relative to CHO-WTα4 cells on 
2D surface (Fig. 6-1B and C).  
It has reported that cells utilize myosin II A to achieve efficient 1D migration (Doyle 
et al., 2009) and this mechanism is analogous to confined migration in our previous 
study (Hung et al., 2013). Because α4 phosphorylation regulates myosin II pathway 
via attenuating Rac1 activity, we also examined the α4 phosphorylation level in 
response to this confinement engineered by microp-patterning. We generated 8µm-
wide fibronectin-printed line where cells were allowed to adhere to form an elongated 
shape (Fig. 6-1D). Similar phenomena were also observed between cells on 1D 
pattern and confinement. Using CHO-α4S988A cells as negative control, CHO-
α4WT cells on 1D fibronectin pattern displayed significantly lower α4 
phosphorylation level relative to ones on 2D printed surface (Fig. 6-1D and E).  These 
data revealed that both physical and adhesive confinement down-regulates α4-
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Figure 6-1. Effects of physical confinement on α4 phosphorylation. (A) Schematic 
of the microchannel device bounded to glass slide. Also shown below is a close-up 
detail of channel array. Channels of 50-µm, 20-µm, 10-µm, 6-µm, and 3-µm in width 
were used in the study. The red arrow (left to the close-up channel array) indicates the 
direction of migration. (B) CHO-α4WT and CHO-α4S988A cells were seeded in cell 
seeding area (indicated as unconfined) and then induced to migrate through 20-µm, 
10-µm, 6-µm, or 3-µm fibronectin-coated channels. Cells expressing GFP-α4 
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integrins were stained with phosphorylated α4 (red) and imaged by dual color 
confocal microcopy. (C) For each designated condition, overall level of α4 
phosphorylation is quantified by measuring α4 phosphorylation red fluorescence 
intensity normalized by GFP-tagged α4 integrin. (D) Schematic representation of 
microcontact printing. (a and b) PDMS stamp (blue) was coated with fibronectin 
(orange) to be printed. (c) Fibronectin was transferred by printing onto cover slide 
(gray) and then examined by fluorescence staining (d). (E) CHO-α4WT and CHO-
α4S988A cells placed on either 2D or 1D fibronectin printed cover slide were stained 
with phosphorylated α4 and imaged by confocal microcopy (F) The overall α4 
phosphorylation level was quantified by measuring α4 phosphorylation red 
fluorescence intensity normalized by GFP-tagged α4 integrin. Data represent means ± 
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6.3.2 PKA activity of CHO-α4WT cells is reduced in response to physical 
confinement 
It has reported that PKA (protein kinase A) is critical to regulate α4 integrin 
phosphorylation at Ser988 (Goldfinger et al., 2003) and α4 integrin functions as one of 
A Kinase Anchoring Proteins (AKAPs) recruiting PKA to cell membrane (Lim et al., 
2007). Therefore we investigate if PKA is the upstream regulator modulating level of 
α4-phosphorylation in response to physical confinement. We evaluated 
compartmentalized PKA activity of CHO-α4WT cells in plasma membrane 
microdomains in unconfined or confined migration by using membrane-targeted 
fluorescence resonance energy transfer (FRET)-based A-Kinase Activity Reporters 
(AKARs-Kras) (Fig. 6-2A). This allows live-cell visualization of endogenous PKA 
activity dynamics with high spatiotemporal resolution. CHO-α4WT cells expressing 
AKAR4-Kras were first allowed to seed on cell seeding area and chemoattractant was 
applied to induce migration through 3µm channels. Time-lapse images demonstrate 
an overall reduction of PKA activity when CHO-α4WT cells transiting from 
unconfined to confined spaces (Fig. 6-3). In order to verify the effect of confinement 
on PKA activity, the PKA activity of CHO-α4WT cells in confined or unconfined 
spaces were first measured by quantifying the starting yellow-cyan emission ratio, 
followed by addition of PKA inhibitor, H89, for 30 minutes to detect the basal level 
of PKA activity (Fig. 6-2). The starting ratio of confined CHO-α4WT cells is 
significantly lower relative to unconfined cells (Fig. 6-2C). Moreover yellow-cyan 
emission ratios were plotted along with yellow intensities, displaying the non-
correlation between emission ratio and transfection efficiency (Fig. 6-2D). Treating 
unconfined cells with 10µM H89 resulted in approximately 20% decrease of PKA 
activity and in contrast, confined cells treated with 10µM H89 results in 
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approximately 9% decrease of PKA activity (Fig. 6-2E). Therefore multiple lines of 
evidences together suggest that PKA activity of CHO-α4WT is reduced in confined 
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Figure 6-2 PKA activity is spatiotemporally modulated by physical confinement. 
(A) Schematic representation of AKAR4-Kras (B) CHO-α4WT cells expressing 
AKAR4-Kras were plated on unconfined spaces or induced to 3µm channel to 
experience confinement. YFP images and ratiometric images of confined and 
unconfined cells before PKA inhibitor, H89, was added (0 min) and at 15 and 30 
minute after the addition. (C) The initial PKA activity of confined or unconfined 
CHO-α4WT cell is quantified by measuring FRET to CFP emission ratio. Data 
presents means ± SEM. *, P < 0.05. (D) FRET to Cyan emission ratios of CHO-
α4WT cells in confined and unconfined spaces are plotted with YFP intensity and 
data points are fitted with linear regression. Correlation coefficient, R2 and p-value 
evaluating fitness are both displayed. (E) CHO-α4WT cells in confined (N=3) or 
unconfined (N=5) space were treated with 10µM H89 and the FRET to Cyan 
emission ratio was recorded every 30 seconds for 40 minutes. Bar graph displays the 
decaying percentage of PKA activity at 30 minute after addition of H89. Data 
presents means ± SEM. *, P < 0.05.    
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Figure 6-3. Change of spatiotemporal PKA activity of CHO-α4WT cells during 
migration transition between 2D surface and confinement. White arrows point 
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6.3.3 Inhibiting and activating PKA activity of CHO-α4WT cells suppress unconfined 
and confined migration respectively 
         It has reported that phosphorylation of α4 cytoplasmic tail regulates Rac1 
activation by inhibiting α4/paxillin binding(Liu et al., 1999; Nishiya et al., 2005). 
Moreover, we also found that the α4-mediated Rac1 activation is in the crosstalk with 
RhoA/myosin II pathway and it tightly regulates migration in response to different 
degree of confinement (Hung et al., 2013). Given that the level of α4 phosphorylation 
and PKA activity were both reduced as increasing degree of confinement, we sought 
to exanimate the effect of inhibiting or activating PKA on migration in unconfined 
versus confined spaces. CHO-α4WT cells were treated with PKA inducer, forskolin 
or PKA inhibitor, Rp-cAMPs and chemoattractant was then applied to induce 
migration through 20 µg/ml fibronectin-coated channel in width of 50µm, 20µm, 
10µm, 6µm, and 3µm. CHO-α4WT cells treated with forskolin displayed a migration 
phenotype where cells migrated with high velocity in wide channels (50µm and 
20µm) but with significantly lower migration velocity in narrow channel (6µm and 
3µm), compared with vehicle control (Fig. 6-4A). In contrast, CHO-α4WT cells 
treated with Rp-cAMPs showed reverse phenotype to forskolin treatment. It 
demonstrates high migration velocity in narrow channels but significant lower 
migration velocity in wide channel (Fig. 6-4A). Because the α4 phosphorylation level 
of CHO-α4WT cells was reduced in both confined and 1D environments (Fig 6-1), 
we also tested CHO-α4WT cells migrating on 8µm-wide linear fibornectin line with 
the treatment of forskolin or Rp-cAMPs. Inhibiting and activating PKA activity 
promotes and suppresses 1D migration respectively in terms of velocity and 
instantaneous speed (Fig 6-4 D and E), which is similar to the phenotype of confined 
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migration. These data suggest that CHO-α4WT cells require reduced and elevated 
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Figure 6-4. Effects of inhibiting or enhancing PKA activity on confined 
migration and 1D migration of CHO-α4WT cells. CHO-α4WT cells were treated 
with either PKA enhancer forskolin, PKA inhibitor Rp-cAMPs, or vehicle control and 
allowed to migrate inside of fibronectin-coated channel (A and B) or on fibronectin-
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printed 8µm wide 1D pattern (C, D, and E). Their migration velocities (A and D) and 
instantaneous speed (E) were quantified. The time-lapse images of migrating cells in 
designated channel widths (B) and 1D pattern (C) are shown. Data represent means ± 
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6.3.4 Activating or inhibiting PKA activity of CHO-α4WT regulates contractility and 
lamellipodia formation.  
          We have reported that CHO-α4WT cells regulate Rac1/myosin II crosstalk 
through α4-mediated signaling. CHO-α4S988A cells with phosphorylation point 
mutation at Ser988 cells displays smaller lamellipodia formation but higher densities of 
focal adhesion and stress fiber (Hung et al., 2013). In contrast the reversed 
phenotypes were observed in CHO-α4Y991A cells with α4/paxillin binding 
mutation(Hung et al., 2013). Because PKA is regulating α4-mediated signaling, it 
encourages us to test the effects of inhibiting or inducing PKA on focal adhesion and 
lamellipodia formation of CHO-α4WT cells. CHO-α4WT cells were first plated on 
fibornectin-coated 2D surface in the treatment of forskolin or Rp-cAMPs and stained 
stress fiber and paxillin were both imaged in each condition (Fig 6-5 A). Punctate 
structure of paxillin were identified and measured to determine the density of focal 
adhesion in designated condition (Fig. 6-5 B). Forskolin treated CHO-α4WT cells 
displayed lower density of focal adhesion but formed larger lamellipodia (Fig. 6-5 A, 
C, and D). In contrast, Rp-cAMPs treated CHO-α4WT cells has higher density in 
terms of the number of focal adhesion normalized by spreading area and total area of 
focal adhesion normalized by cell spreading area (Fig. 6-5A and C). However, the 
areas of cell spreading and lamellipodia formation of Rp-cAMPs treated CHO-α4WT 
cells were significantly smaller than those of vehicle control and forskolin treated 
CHO-α4WT cells (Fig. 6-5D). These results imply that the myosin II and protrusion 
activities of CHO-α4WT cells can be regulated by PKA activity.   
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Figure 6-5. Effects of inducing or inhibiting PKA activity on focal adhesion 
densities and lamellipodia formation of CHO-α4WT cells on 2D surfaces. CHO-
α4WT cells were plated on fibronectin-coated coverslips in presence of vehicle 
control, PKA inhibitor Rp-cAMPs, or PKA inducer forskolin. (A) Cells stained with 
phalloidin (green) and with an antibody against paxillin (red) were imaged by 
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confocal microcopy. Focal adhesion images (B, a) were first processed by background 
subtraction and binary conversion (B, b) and then identified and measured by imageJ 
software (B, c). Focal adhesion densities were evaluated as the number of focal 
adhesions (FA) per micrometer squared (C, a) or total area of focal adhesions 
normalized by cell spreading area (C, b) in designated conditions. Averaged focal 
adhesion areas within cells were also quantified (C, c). Cell spreading areas (D, a) and 
the area of lamellipodia protrusion (D, b) were quantified. Data represent means ± 
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6.3.5  α4 and α5 amplify PKA signaling but not serve as mechanosenser to physical 
constraint.  
      It has reported that α4 and α5 integrins play the important role to induce PKA 
gradient in migration CHO cells (Lim et al., 2008). Other study also revealed that 
release of cAMP gating is mediated through α6β4 signaling pathway (O'Connor et al., 
1998). Given the fact that integrins play the critical role in regulating cAMP and PKA 
activity, we next investigate if the reduced PKA of in confinement is resulted from 
integrins. We have evaluated PKA activity of three cell lines expressing α4 and α5 
(CHO-α4WT cells), only α5 (CHO cells), and neither α4, α5, nor other integrins 
(CHO-B2)(Chen et al., 2012). Interestingly, we found that PKA activity is 
significantly reduced in 3µm channel in CHO-α4WT, CHO, and CHO-B2 cells, 
relative to cells on unconfined spaces (6-6 A). CHO-α4WT, CHO, and CHO-B2 
display gradient from leading to trailing edges on 2D surface. In contrast, confined 
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Fig. 6-6 comparison of PKA activity of CHO-α4WT, CHO, and CHO-B2 cel 
lines in unconfined versus confined spaces. (A) CHO-α4WT, CHO, or CHO-B2 
cels expressing AKAR4-Kras were plated on unconfined spaces or induced to 3µm 
channel to experience confinement. Profile plots shown are the averaged ratiometric 
values for six line scans centered around the dashed tracing (B) The initial PKA 
activity of confined or unconfined cel is quantified by measuring FRET to CFP 











Our microchannel assay provides a systematic means to examine migratory 
behaviors in response to varying degrees of confinement, where the absence of 
confinement (wide channels where W>dcell) mimics a 2D environment. This enables 
us to directly compare and contrast 2D versus confined migration in a quantitative 
manner, and to elucidate the mechanisms underlying these two regimes. Using this 
assay, we examined several fibroblast-like cell types expressing or lacking α4β1 
integrin. Fibroblast-like cells, including the α4β1 integrin-expressing CHO cells and 
A375-SM cells, employ a ‘mesenchymal mode’ of migration on 2D surfaces, in 
which lamellipodia protrusion and cell-ECM adhesion play critical roles. In contrast, 
cells migrating through physically confined spaces display less extensive protrusive 
activity at the leading edge. This migration mode depends on myosin II-driven 
contractility, akin to amoeboid migration of T lymphocytes(Jacobelli et al., 2010; 
Yoshida and Soldati, 2006). Unlike lymphocytes, however, CHO-α4WT and A375-
SM cells in narrow channels retain well-organized stress fibers, which are reminiscent 
of those observed in fibroblasts in a 3D linear elastic environment or under other 
forms of physical constraints (Doyle et al., 2009; Ghibaudo et al., 2009; Petrie et al., 
2012). It is possible that in response to the physical constraints, fibroblast-like cells 
switch their migration mode to become more amoeboid-like while still retaining some 
mesenchymal characteristics; specific cell types may possess certain degrees of 
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mesenchymal or amoeboid characteristics. In response to confinement or other 
physical constraints, the cells may undergo different degrees of mesenchymal-to-
amoeboid transition, during which the strategy for optimizing cell migration has to be 
altered. It can be envisioned that myosin II-driven contractility of fibroblast-like cells 
may facilitate confined migration by laterally constraining the cell body, thus 
minimizing cell-substrate contact interactions (Sixt, 2012). On the other hand, Rac1-
dependent lamellipodia protrusion rather than the myosin II-driven contractility 
becomes more critical in 2D migration. To adapt to different degrees of confinement, 
the cells optimize the signaling network by adjusting the balance between Rac1 and 
myosin II activities.  
The α4/paxillin-mediated signaling network (Fig. 7-1) provides a paradigm 
for such adaptation in response to altered physical environment. On a 2D surface, 
α4β1 integrin promotes the migration of CHO-α4WT cells by optimizing Rac1 
activity at the cell front (Goldfinger et al., 2003). The elevated Rac1 activity is 
maintained by Ser988-phosphorylation at the α4 cytoplasmic tail that prevents 
α4/paxillin binding. In contrast, as cells experience increasing degrees of 
confinement, α4/paxillin binding becomes progressively indispensible for effective 
migration. Therefore, the levels of α4/paxillin binding and Ser988-phosphorylation are 
modulated as CHO-α4WT cells migrate in different microenvironments. The 
mechanism of this signaling adaptation in response to physical confinement is beyond 
the scope of this paper, but we can envision three possible mechanisms. First, Ser988-
phosphorylation and its downstream targets could be regulated via α4β1-ligand 
engagement, where α4β1 integrin functions as a mechanosensor. For instance, it has 
been reported that engagement of α4β1-specific ligand down-regulates RhoA and 
stress fiber formation in A375-SM cells plated on 2D surfaces (Moyano et al., 2003). 
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Although our data show that under confinement VCAM-1 is not required for CHO-
α4WT and A375-SM cells to reach maximum migration velocities, ECM proteins, 
such as fibronectin, may be secreted by the cells over the course of the microchannel 
assay and/or deposited from the chemoattractant (FBS) source, thereby providing 
force signals. This opens a second possibility: other integrins or cell surface receptors 
may act as mechanosensors (Jalali et al., 2001; Li et al., 2002; Roca-Cusachs et al., 
2012) that regulate the cellular responses to physical confinement. A third possible 
mechanism is that the cytoskeleton itself may function as a mechanosensor (Janmey 
and Weitz, 2004; Ren et al., 2009; Schwarz and Gardel, 2012). The actomyosin 
network may sense the mechanical cues generated by confinement-induced cell shape 
changes (McBeath et al., 2004), leading to the observed cellular responses.  
We show that disrupting α4/paxillin binding in α4β1-expressing CHO and 
A375-SM cells inhibits myosin II-driven contractility, and this defect can be rescued 
by treating cells with a Rac1 inhibitor. Likewise, treatment of fibroblasts and CHO 
cells lacking α4β1 integrin with the Rac1 inhibitor augments migration in narrow 
channels by promoting myosin II-driven contractility. Moreover, blebbistatin 
increases migration velocity in wide channels via enhancement of Rac1 activity. We 
further show that the Rac1 inhibitor also has a rescue effect on primary CD4+ T cells 
carrying the α4Y991A mutation, which is similar to that of CHO-α4WT and A375-
SM cells under confinement. These observations support a crosstalk mechanism in 
which Rac1 and myosin II negatively regulate each other to modulate cell motility 
(Fig. 7-1). Crosstalk between Rac1 and myosin II and vice versa has been reported by 
numerous studies (Burridge and Wennerberg, 2004; Bustos et al., 2008). Rac1 can 
inhibit myosin II-driven contractility by several mechanisms. For example, Rac1 can 
inhibit Rho by activating p190RhoGAP (Nimnual et al., 2003). Rac1 can also inhibit 
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myosin II activities by promoting phosphorylation of MLCK (Sanders et al., 1999) or 
myosin II heavy chain (Leeuwen et al., 1997) via PAK or by inhibiting 
phosphorylation of myosin II regulatory light chain via WAVE2 (Sanz-Moreno et al., 
2008).   
Our data reveal that MIIB but not MIIA is required for optimizing 2D 
migration, whereas this scenario is reversed for confined migration. These 
observations are in agreement with published data showing that MIIB and MIIA have 
overlapping but differential functions in cell migration. MIIA is required for stress 
fiber formation, cellular contractility and trailing edge retraction (Even-Ram et al., 
2007; Sandquist et al., 2006; Vicente-Manzanares et al., 2011; Vicente-Manzanares et 
al., 2007). It has been proposed that MIIA is the predominant downstream target for 
the Rho pathway, which is based on observations showing that MIIA-depletion has 
similar effects as blebbistatin or Y-27632 treatment. Indeed, we also observed that 
MIIA-depletion had similar effects as inhibiting ROCK or the enzyme cycle of 
myosin II; all interventions impaired confined, but not 2D, migration, thus suggesting 
that MIIA-driven contractility is critical for the efficient migration of CHO-α4WT 
cells under physical confinement (Fig. 7-1). In contrast to MIIA, MIIB plays a 
relatively minor role in cellular contractility, as demonstrated by traction force 
measurements and stress fiber evaluations of MIIA- and MIIB-deficient mouse 
embryonic fibroblasts (Cai et al., 2006). Instead, MIIB stabilizes front-back polarity 
of migrating cells (Vicente-Manzanares et al., 2011; Vicente-Manzanares et al., 2007) 
and contributes to leading edge protrusion (Giannone et al., 2007). Consistent with 
these studies, we have shown that MIIB-depleted CHO-α4WT cells on 2D substrates 
exhibited a rounded morphology and polarity defects, which greatly inhibited 2D 
migration. However, this molecular intervention had little or no inhibitory effect on 
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confined migration. Inhibition of MLCK impairs the activation of both MIIA and 
MIIB, leading to reduced migration in both wide and narrow channels. This 
observation suggests that in wide channels MIIB-depletion may be dominant over the 
potential elevation of Rac1 induced by suppressed MIIA activity.  
Altogether, the first part of study (Chapter 2, 3, 4 and 5) reveals that distinct 
mechanisms regulate cell migration in 2D versus confined spaces, which involves 
Rac1-myosin II crosstalk. The α4β1-mediated pathway provides a paradigm for the 
plasticity of cells in which a signaling network can be tuned in distinct manners in 
response to different physical conditions to achieve maximal cell motility.  We then 
elucidated how the mechanical signals generated by physical confinement induce 
cellular responses and how cells alter their signaling strategies to optimize cell 
motility.  
As described in Chapter 6, PKA phosphorylates α4 cytoplasmic tail and 
serves as upstream regulator to wide variety of enzyme. Our study has revealed that 
membrane-PKA activity was reduced when cells experience confinement, which is 
not resulted by α4β1 or α5β1 integrin expression. However, α4β1 and α5β1 integrin 
both enhances PKA gradient cross cell body in both confined and unconfined spaces. 
This implies that α4β1 and α5β1 can either promote or function as AKAPs in leading 
edge. Chemoattractant activates Rac1, in turns triggering the recruitment of actin 
nucleation protein Arp2/3 and WAVEs to facilitate net-like actin polymerization.  
Given that WAVEs, functioning AKAPs, localizes PKA to leading edge, therefore we 
hypothesize that for the cell doesn’t express α4β1 integrins, PKA activity at the 
leading edge is first accomplished by actin nucleation (WAVEs) that is activated by 
chemoattractants. In regions away from the leading edge, Rac1 and myosin II are in 
balance due to lack of external signals.  However, α4β1 integrins can amplify the 
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signaling of PKA activation by recruiting PKA to leading edge as AKAPs. 	  PKA 
gradient is established by WAVEs but amplified by a4.  In regions away from the 
leading edge, the balance between Rac1 and myosin II is broken by a4/paxillin that 
inhibits Rac1 and enhances myosin II.  
In confinement, actin polymerization displays a bipolar pattern where also 
locates water channels, focal adhesion, and several types of integrin(Stroka et al., 
2014). Confined cell demonstrates highly aligned structure of stress fiber, which 
connects to both ends of cell body (Hung et al., 2013). These evidences together 
imply that confined cells preferentially locate wide variety of molecules to the part 
exposed to open space. On the other hand, it has reported that filamentous actin serves 
in a mechano-sensitive capacity itself and compressive force prevents Arp2/3 from 
further actin polymerization (Risca et al., 2012). We can therefore suggest that 
reduced PKA activity in confined cells is possibly resulted from the limitation of actin 
polymerization against the wall where cytoskeleton associating AKAPs is prevented 
to develop.  
It as been well studied that PKA phosphorylates RhoA on Ser188, leading to 
increased RhoGDI association and decreased RhoA signaling (Wong and Scott, 
2004). PKA activation on AKAP-Lbs also inhibits Rho-GEF activity, thereby 
preventing the activation of RhoA (Wong and Scott, 2004). We have shown that the 
local PKA activity is reduced in confinement, which is possibly due to restricted 
spatial actin polymerization. Therefore RhoA/myosin II activity can elevate at the part 
where PKA is reduced. This phenomena support our initial point that in physical 
constraint, cell up-regulates RhoA/myosin activity to optimize confined migration by 
switching toward myosin II-driven migration mode. For α4-expressing cell lines, this 
PKA reduction likely enhances myosin II activity via α4/paxillin binding, thus 
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promoting confined migration speed in α4-expressing cell line as we have observed in 
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Figure 7-1 Model and summary of α4-tail-mediated signaling in optimizing 2D 
and confined migrations.  (A) The tables summarize the effects of introducing the 
α4 tail mutations or various pharmacological inhibitors/siRNAs on the migration of 
α4 integrin-expressing CHO cells through wide (W) and narrow (N) channels.  (B) 
Distinct signaling pathways regulate 2D versus confined migration.  Black lines: 
primary pathway; orange lines: end result from several signaling steps; black dashed 
lines: involved but not required.   
 
 




Suggested future work 
8.1 Evaluating effect of confinement on gene regulation in microarray analysis 
      It is well established that the nucleus plays an important role in 
mechanotransduction signaling where the process of biochemical signal propagation 
and processing, as most signaling pathways eventually culminate with nuclear 
proteins binding to specific genomic elements to modulate transcription. It is also 
known that the nucleus is mechanically connected to the rest of the cell via LINC 
(Linker of Nucleoskeleton and Cytoskeleton) complex structures in the nuclear 
envelope(Chambliss et al., 2013). These complexes play similar role of focal 
adhesions at the plasma membrane, allowing for cytoskeletal and external forces to 
result in nuclear deformations. According to Greogory R. Fedorchak, nucleus 
deformation could result in change of expression level by altering the interaction 
between chromatin and nuclear lamina, calcium or other ion influx to nucleus, or 
force transmitted across the LINC protein to alter gene location(Wang et al., 2009a).  
In general, force-generated conformational change of protein at nucleus envelope or 
interior can expose the active site of protein, thus further facilitating interaction or 
phosphorylation of protein.  Moreover, nowadays we know that chromosome, in 
nucleus, has high spatial specificity; deformation of nucleus could bring specific gene 
close to nucleus pore or active protein site of nucleus envelope or interior nucleus.  
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Given that cells in 1D substrate line and confinement have elongated nucleus 
morphology(Khatau et al., 2012), besides actin and myosin II, those speculated 
mechano-sensor as prescribed in prior chapters, the compression of nucleus could also 
likely induces regulation of gene expression by deforming the nucleus shape. We 
have maturely developed the method to purify sufficient quantity of m-RNA from 
confined cell on 1D pattern. This allows us to probe the modification of gene 
regulation of confined cell relative to unconfined cells via microarray analysis (Fig 8-
1). 
8.2 Evaluating the role of α4 integrin in metastatic potential of glioblastoma (GMB) 
in brain micro-vessel network.   
     Vascular cell adhesion molecule-1 (VCAM-1) is an endothelial cell 
membrane glycoprotein that has been implicated in leukocyte/endothelial cell 
interactions in inflammation. It has been reported that human brain micro-vessel 
(diameter: 5~10 µm) endothelial cells (HBMEC) expresses high level of VCAM-1. 
Symptoms of a glioblastoma multiform in adults includes seizures, paralysis of area 
of body, changes in behavior, memory, or thinking abilities. α4β1-expressing 
glioblastoma cell (GMB) migrates in brain through VCAM-1 expressing micro-vessel 
network (Fig. 8-2), which is akin to PDMS-based microchannel developed in our lab. 
Therefore it is critical to reveal if GMB metastasis can be inhibited through 
modulating α4 cytoplasmic signaling in terms of confined migration. In prior chapter, 
we have employed α4/paxillin inhibitor to inhibit confined migration of α4-
expression melanoma cell (A375-SM), Jurkat T-cells and, CD4+ T-cells. Therefore, 
investigating if this α4/paxillin inhibitor could also prevent glioblasoma metastasis in 
brain composed of micro-vessel network with high VCAM-1 expression becomes an 
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important study. This study can first be performed in in-vitro PDMS-based 
microchannel assay, followed by the evaluation of the metastatic potential of 
glioblastroma cells migrating in brain tissue based on the conditions established in 
vitro. The results of this investigation will shed the light on potential cure of brain 
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Figure 8-1 the procedure to evaluate gene regulation of confined (1D) and 
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Figure 8-2. Metastasis of glioblastoma cells in mouse brain tissue. α4 expressing 
level of glioblastoma cell was evaluated by flow cytometry, relative to control 
(upright image). Time-lapse images demonstrate glioblastoma metastasis within 
micro-vessel of mouse brain tissue.   
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C: 443-931-2849  
wayne8000@gmail.com 
EDUCATION and TRAINING 
PhD candidate, Chemical and Biomolecular Engineering          09/2009 ~ 03/2014 
• Johns Hopkins University, Baltimore, Maryland  
• Cumulative GPA: 3.9                                                              
• Advisor: Dr. Konstantinos Konstantopoulos 
Master of Science, Chemical Engineering                                    08/2007 ~ 08/2009 
• Johns Hopkins University Bloomberg School of Public Health, Baltimore, 
Maryland  
• MHS in Bioinformatics 
• Advisor: Dr. Fernando Pineda 
Bachelor of Science, Chemical Engineering                                 09/2002 ~ 06/2007 
• Missouri University-Columbia 
• B.S. in Biochemistry, Minor in Mathematics 




Fluorescent Microscopy, Confocal Microscopy, Cell culture, Virus 
transfection/transduction, High throughput and high content assays, Western Blot, 
Microfluidic devices, Flow cytometry (FACS)
 
Analytical chemistry-related 
Scanning Electron Microscope (SEM), Tunneling Electron Microscope (TEM), 
Energy Dispersive X-ray Spectroscopy (XRD), Optical Spectroscopy, Raman 
Spectroscopy, Thermogravimetric Analysis (TGA), Fourier Transform Infrared 
Spectroscopy (FTIR), Photolithography, Atomic Force Microscopy 
 
PROFESSIONAL EXPERIENCE 
Predoctoral research fellow                                                                                       
10/2009 ~ Present  
Physical Science - Oncology Center, Johns Hopkins University 
• Topic: Distinct signaling mechanisms regulate migration in unconfined 
versus confined spaces: Used novel microchannel assay to probe the alpha4 
integrin mediated signaling and the crosstalk between Rac1 and Myosin II 
pathway. 
• Topic: Fluid Shear Promotes Chondrosarcoma Cell Invasion by 
Activating Matrix Metalloproteinase-12 via IGF-2- and VEGF-Signaling 
Pathways: Develop unique micro-channel based invasion and migration assay 
to simulate in vivo cancer metastasis regulated by MMP-12 pathway. 
• Topic: Cell migration adapts physical environments via modulating 
protein kinase A activity: Applied FRET (fluorescence resonance energy 
transfer) based PKA biosensor to probe global/local PKA cellular activity in 
response to different degrees of physical confinement. 









• General: Provide advise and mentor 6 undergraduate, master and graduate 
students on their research; Collaborate with several postdocs, pathologists, 
oncologists, and cell biologist from Johns Hopkins medical school and continue 
developing new projects; Maintain safe laboratory environment as lab safety 
officer. 
Department of Biostatistics                                                                                       
9/2007 ~ 9/2009  
Johns Hopkins University Bloomberg School of Public Health  
• Topic: developed a mosquito-human interacting model to predict the incidence 
of malaria. 
 
PUBLICATIONS (6 publications; 100 citations, until September 2014) 
• Hung WC, Chen SH, Paul CD, Stroka KM, Lo YC, Yang JT, Konstantopoulos K. 
(2013) "Distinct signaling mechanisms regulate migration in unconfined versus 
confined spaces" J Cell Biol. 202(5):807-24 (highlighted by J Cell Biol; selected 
by F1000Prime) 
• Wang P*, Chen SH*, Hung WC* (*equally contributed), Paul CD, Zhu F, Guan P, 
Huso DL, Kontrogianni- Konstantopoulos A, Konstantopoulos K "Fluid Shear 
Promotes Chondrosarcoma Cell Invasion by Activating Matrix Metalloproteinase-
12 via IGF-2- and VEGF-Signaling Pathways" Oncogene, in press. 
• Hung WC*, Jessica Yang* (*equally contributed), Gu ZZ, Yankaskas C, 
Chaing J, Zhang J, Yang JT, Konstantopoulos K."Cell migration adapts physical 
environments via modulating protein kinase A activity", in preparation. 
• Chen SH, Hung WC, Wang P, Paul CD, Konstantopoulos K. (2013)"Mesothelin 
binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion 
via MMP-7 activation" Sci Rep. 3:1870 
• Norris LC, Fornadel CM, Hung WC, Pineda FJ, Norris DE (2010) "Frequency of 
multiple blood meals taken in a single gonotrophic cycle by Anopheles arabiensis 
mosquitoes in Macha, Zambia." Am J Trop Med Hyg. 83(1):33-7 
• Tong Z, Balzer EM, Dallas MR, Hung WC, Stebe KJ, Konstantopoulos K (2012) 
"Chemotaxis of cell populations through confined spaces at single-cell resolution" 
PLoS One. 7(1):e29211 
• Balzer EM, Tong Z, Paul CD, Hung WC, Stroka KM, Boggs AE, Martin SS, 
Konstantopoulos K (2012) "Physical confinement alters tumor cell adhesion and 
migration phenotypes" FASEB J. 26(10):4045-56 
 
HONORS AND ACTIVITY 
• Dean list from Missouri University-Columbia (2002-2007) 
• Golden Key honor society 
• Phi Beta Kappa honor society 
• Article selected by F1000Prime "Distinct signaling mechanisms regulate 
migration in unconfined versus confined spaces" 
 
TEACHING EXPERIENCE 
Teaching Assistant                                                                           01/2012 – 05/2012 
Department of Chemical and Biomoleuclar Engineering, Johns Hopkins University, 
Baltimore, MD 
Course: Transport Phenomena – Fluid Dynamics, Heat, and Mass Transfer 
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• Hold review sections and homework recitations for eighty undergraduate 
students every two weeks 
Teaching Assistant                                                                           01/2008 – 05/2008 
Department of Biostatistics, Johns Hopkins University, Baltimore, MD  
Course: General Biostatistics 
• Supervised twenty graduate students from different departments to develop 
general biostatistics skill 
 
Affiliations and Activities 
• Chemical and Biomolecular Engineering department (Johns Hopkins University), 
GSLC committee (2010) 
• Taiwanese Students Association Chair assistant (2010) 
• INBT (institute of Nano-biotechnology) mini-symposium convener (2012)
